Regulation	O
of	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-18	I-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
expression	O
on	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
during	O
T	O
helper	O
(	O
Th	O
)	O
1/Th2	O
differentiation	O
.	O

Critical	O
downregulatory	O
role	O
of	O
IL-4	B-protein
.	O

Interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-18	I-protein
has	O
been	O
well	O
characterized	O
as	O
a	O
costimulatory	B-protein
factor	I-protein
for	O
the	O
induction	O
of	O
IL-12-mediated	B-protein
interferon	I-protein
(	I-protein
IFN	I-protein
)	I-protein
-gamma	I-protein
production	O
by	O
T	B-cell_type
helper	I-cell_type
(	I-cell_type
Th	I-cell_type
)	I-cell_type
1	I-cell_type
cells	I-cell_type
,	O
but	O
also	O
can	O
induce	O
IL-4	O
production	O
and	O
thus	O
facilitate	O
the	O
differentiation	O
of	O
Th2	B-cell_type
cells	I-cell_type
.	O

To	O
determine	O
the	O
mechanisms	O
by	O
which	O
IL-18	B-protein
might	O
regulate	O
these	O
diametrically	O
distinct	O
immune	O
responses	O
,	O
we	O
have	O
analyzed	O
the	O
role	O
of	O
cytokines	B-protein
in	O
the	O
regulation	O
of	O
IL-18	B-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
(	O
IL-18Ralpha	B-protein
)	O
expression	O
.	O

The	O
majority	O
of	O
peripheral	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
constitutively	O
expressed	O
the	O
IL-18Ralpha	B-protein
.	O

Upon	O
antigen	O
stimulation	O
in	O
the	O
presence	O
of	O
IL-12	B-protein
,	O
marked	O
enhancement	O
of	O
IL-18Ralpha	B-protein
expression	O
was	O
observed	O
.	O

IL-12	B-protein
-mediated	O
upregulation	O
of	O
IL-18Ralpha	B-protein
required	O
IFN-gamma	B-protein
.	O

Activated	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
that	O
expressed	O
low	O
levels	O
of	O
IL-18Ralpha	B-protein
could	O
produce	O
IFN-gamma	B-protein
when	O
stimulated	O
with	O
the	O
combination	O
of	O
IL-12	B-protein
and	O
IL-18	B-protein
,	O
while	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
which	O
expressed	O
high	O
levels	O
of	O
IL-18Ralpha	B-protein
could	O
respond	O
to	O
IL-18	B-protein
alone	O
.	O

In	O
contrast	O
,	O
T	O
cell	O
stimulation	O
in	O
the	O
presence	O
of	O
IL-4	B-protein
resulted	O
in	O
a	O
downregulation	O
of	O
IL-18Ralpha	B-protein
expression	O
.	O

Both	O
IL-4	B-cell_type
(	I-cell_type
-/	I-cell_type
)	I-cell_type
-	I-cell_type
and	I-cell_type
signal	I-cell_type
transducer	I-cell_type
and	I-cell_type
activator	I-cell_type
of	I-cell_type
transcription	I-cell_type
(	I-cell_type
Stat	I-cell_type
)	I-cell_type
6	I-cell_type
(	I-cell_type
-/	I-cell_type
)	I-cell_type
-	I-cell_type
T	I-cell_type
cells	I-cell_type
expressed	O
higher	O
levels	O
of	O
IL-18Ralpha	B-protein
after	O
TCR	O
stimulation	O
.	O

Furthermore	O
,	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
from	O
Stat6	O
(	O
-/	O
)	O
-	O
mice	O
produced	O
more	O
IFN-gamma	B-protein
in	O
response	O
to	O
IL-18	B-protein
than	O
wild-type	O
controls	O
.	O

Thus	O
,	O
positive/negative	O
regulation	O
of	O
the	O
IL-18Ralpha	B-protein
by	O
the	O
major	O
inductive	O
cytokines	B-protein
(	O
IL-12	B-protein
and	O
IL-4	B-protein
)	O
determines	O
the	O
capacity	O
of	O
IL-18	B-protein
to	O
polarize	O
an	O
immune	O
response	O
.	O

Regulation	NULL
of	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-18	NULL
Receptor	NULL
a	NULL
Chain	NULL
Expression	NULL
on	NULL
CD4~	NULL
T	NULL
Cells	NULL
during	NULL
T	NULL
Helper	NULL
(	NULL
Th	NULL
)	NULL
1/Th2	NULL
Differentiation	NULL
:	NULL
Critical	NULL
Downregulatory	NULL
Role	NULL
of	NULL
IL-4	NULL
Ronald	NULL
B.	NULL
Smeltz	NULL
,	NULL
'	NULL
June	NULL
Chen	NULL
,	NULL
``	NULL
?	NULL

Jane	NULL
Hu-Li	NULL
,	NULL
!	NULL

and	NULL
Ethan	NULL
M.	NULL
Shevach	NULL
'	NULL
'Laboratory	NULL
of	NULL
Immunology	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Research	NULL
Scholars	NULL
Program	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20814	NULL
Abstract	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-18	NULL
has	NULL
been	NULL
well	NULL
characterized	NULL
as	NULL
a	NULL
costimulatory	NULL
factor	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-12-mediated	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
-y	NULL
production	NULL
by	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
1	NULL
cells	NULL
,	NULL
but	NULL
also	NULL
can	NULL
induce	NULL
IL-4	NULL
production	NULL
and	NULL
thus	NULL
facilitate	NULL
the	NULL
differentiation	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-18	NULL
might	NULL
regulate	NULL
these	NULL
diametrically	NULL
distinct	NULL
immune	NULL
responses	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
role	NULL
of	NULL
cytokines	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-18	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
IL-18Ra	NULL
)	NULL
expression	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
peripheral	NULL
CD4*	NULL
T	NULL
cells	NULL
constitutively	NULL
expressed	NULL
the	NULL
IL-18Rax	NULL
.	NULL

Upon	NULL
antigen	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
marked	NULL
enhancement	NULL
of	NULL
IL-18Rax	NULL
expression	NULL
was	NULL
observed	NULL
.	NULL

IL-12-mediated	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
required	NULL
IFN-y	NULL
.	NULL

Activated	NULL
T	NULL
cells	NULL
that	NULL
expressed	NULL
low	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
could	NULL
produce	NULL
IFN-y	NULL
when	NULL
stimulated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
while	NULL
CD4*	NULL
cells	NULL
which	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
could	NULL
respond	NULL
to	NULL
IL-18	NULL
alone	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
cell	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
resulted	NULL
in	NULL
a	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

Both	NULL
IL-4~	NULL
``	NULL
~	NULL
and	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
6~	NULL
``	NULL
~-	NULL
T	NULL
cells	NULL
expressed	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
after	NULL
TCR	NULL
stimulation	NULL
.	NULL

Furthermore	NULL
,	NULL
activated	NULL
T	NULL
cells	NULL
from	NULL
Stat6~'~	NULL
mice	NULL
produced	NULL
more	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
than	NULL
wild-type	NULL
controls	NULL
.	NULL

Thus	NULL
,	NULL
positive/negative	NULL
regulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
by	NULL
the	NULL
major	NULL
inductive	NULL
cytokines	NULL
(	NULL
IL-12	NULL
and	NULL
IL-4	NULL
)	NULL
determines	NULL
the	NULL
capacity	NULL
of	NULL
IL-18	NULL
to	NULL
polarize	NULL
an	NULL
immune	NULL
response	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
Introduction	NULL
IL-18	NULL
is	NULL
an	NULL
18-kD	NULL
cytokine	NULL
originally	NULL
described	NULL
as	NULL
IFN-y-inducing	NULL
factor	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
augment	NULL
IFN-y	NULL
production	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
IL-18	NULL
has	NULL
been	NULL
regarded	NULL
as	NULL
a	NULL
proinflammatory	NULL
cytokine	NULL
that	NULL
can	NULL
synergize	NULL
with	NULL
IL-12	NULL
to	NULL
increase	NULL
IFN-y	NULL
production	NULL
,	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
,	NULL
and	NULL
Th1	NULL
responses	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

While	NULL
IL-18	NULL
clearly	NULL
enhances	NULL
Th1	NULL
responses	NULL
,	NULL
it	NULL
is	NULL
less	NULL
clear	NULL
whether	NULL
IL-18	NULL
is	NULL
capable	NULL
of	NULL
initiating	NULL
Th1	NULL
differentiation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
6-10	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
majority	NULL
of	NULL
published	NULL
reports	NULL
link	NULL
IL-18	NULL
with	NULL
Thi-associated	NULL
functions	NULL
,	NULL
IL-18	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
augment	NULL
Th2	NULL
responses	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

Administration	NULL
of	NULL
IL-18	NULL
to	NULL
mice	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
IL-4	NULL
production	NULL
and	NULL
elevated	NULL
serum	NULL
IgE	NULL
.	NULL

The	NULL
mechanisms	NULL
whereby	NULL
IL-18	NULL
can	NULL
influence	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
responses	NULL
are	NULL
unclear	NULL
at	NULL
this	NULL
time	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Ethan	NULL
M.	NULL
Shevach	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bldg	NULL
.	NULL

10	NULL
,	NULL
Rm	NULL
.	NULL

11N315	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Phone	NULL
:	NULL
301-496-6449	NULL
;	NULL
Fax	NULL
:	NULL
301-496-0222	NULL
;	NULL
E-mail	NULL
:	NULL
ems1	NULL
@	NULL
mail.nih.gov	NULL
IFN-y-inducing	NULL
factor	NULL
*	NULL
IL-12	NULL
«	NULL
IL-1R-related	NULL
protein	NULL
®	NULL
Stat	NULL
*	NULL
IFN-y	NULL
The	NULL
IL-18R	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
known	NULL
chains	NULL
,	NULL
IL-18	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
IL-18Ra	NULL
)	NULL
*	NULL
and	NULL
IL-18RB	NULL
(	NULL
15-20	NULL
)	NULL
.	NULL

IL-18Ra	NULL
(	NULL
IL-1R5	NULL
)	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
IL-1	NULL
receptor-related	NULL
protein	NULL
(	NULL
IL-1Rrp	NULL
)	NULL
because	NULL
of	NULL
its	NULL
homol-ogy	NULL
with	NULL
the	NULL
IL-1/Toll	NULL
receptor	NULL
family	NULL
and	NULL
is	NULL
the	NULL
extracellular	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
IL-18R	NULL
complex	NULL
.	NULL

IL-18RB	NULL
(	NULL
also	NULL
known	NULL
as	NULL
IL-18RAcPL	NULL
or	NULL
IL-1R7	NULL
)	NULL
is	NULL
the	NULL
signal	NULL
trans-ducing	NULL
chain	NULL
of	NULL
the	NULL
IL-18R	NULL
complex	NULL
and	NULL
is	NULL
also	NULL
a	NULL
member	NULL
of	NULL
the	NULL
IL-1R	NULL
family	NULL
.	NULL

It	NULL
has	NULL
been	NULL
widely	NULL
believed	NULL
that	NULL
the	NULL
IL-18Ra	NULL
is	NULL
not	NULL
expressed	NULL
on	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
is	NULL
induced	NULL
during	NULL
differentiation	NULL
of	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
Th2	NULL
,	NULL
cells	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
recently	NULL
developed	NULL
polyclonal	NULL
antibody	NULL
to	NULL
IL-18Ra	NULL
to	NULL
investigate	NULL
regulation	NULL
of	NULL
its	NULL
expression	NULL
on	NULL
differentiating	NULL
CD4*+*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
resting	NULL
peripheral	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
*Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
IL-18Ra	NULL
,	NULL
IL-18	NULL
receptor	NULL
@	NULL
chain	NULL
;	NULL
MFI	NULL
,	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
;	NULL
NMS	NULL
,	NULL
normal	NULL
mouse	NULL
serum	NULL
;	NULL
RAG	NULL
,	NULL
recombination	NULL
activating	NULL
gene	NULL
;	NULL
Stat	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
.	NULL

143	NULL
The	NULL
Journal	NULL
of	NULL
Experimental	NULL
Medicine	NULL
*	NULL
Volume	NULL
194	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
July	NULL
16	NULL
,	NULL
2001	NULL
143-153	NULL
http	NULL
:	NULL
//www.jem.org/cgi/content/full/194/2/143	NULL
cells	NULL
express	NULL
IL-18Rax	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
IL-12	NULL
alone	NULL
may	NULL
upregulate	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
,	NULL
culture	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
IL-12	NULL
or	NULL
IL-18	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
TCR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
but	NULL
not	NULL
IL-18	NULL
,	NULL
resulted	NULL
in	NULL
marked	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
IL-18	NULL
and	NULL
IL-12	NULL
further	NULL
enhanced	NULL
IL-18Ra	NULL
expression	NULL
during	NULL
TCR	NULL
activation	NULL
.	NULL

Although	NULL
IFN-y	NULL
did	NULL
not	NULL
directly	NULL
regulate	NULL
IL-18Ra	NULL
expression	NULL
,	NULL
IL-12-mediated	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IFN-y	NULL
.	NULL

After	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
CD4¢*	NULL
T	NULL
cells	NULL
to	NULL
produce	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
alone	NULL
correlated	NULL
with	NULL
their	NULL
expression	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
IL-18Ra	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
TCR	NULL
ligation	NULL
and	NULL
IL-4	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
on	NULL
unprimed	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
downregulatory	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
were	NULL
completely	NULL
dependent	NULL
on	NULL
expression	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
6	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-18Ra	NULL
expression	NULL
is	NULL
finely	NULL
regulated	NULL
during	NULL
the	NULL
course	NULL
of	NULL
CD4+*	NULL
T	NULL
cell	NULL
differentiation	NULL
along	NULL
either	NULL
the	NULL
Th1	NULL
or	NULL
Th2	NULL
pathways	NULL
.	NULL

They	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
IL-12/IFN-y	NULL
play	NULL
a	NULL
critical	NULL
function	NULL
in	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
during	NULL
differentiation	NULL
along	NULL
the	NULL
Th1	NULL
pathway	NULL
,	NULL
while	NULL
IL-4	NULL
plays	NULL
a	NULL
downregulatory	NULL
role	NULL
on	NULL
IL-18Ra	NULL
during	NULL
Th2	NULL
differentiation	NULL
.	NULL

These	NULL
data	NULL
are	NULL
critical	NULL
to	NULL
furthering	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
proposed	NULL
dual	NULL
role	NULL
of	NULL
IL-18	NULL
as	NULL
a	NULL
differentiation	NULL
factor	NULL
for	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
responses	NULL
as	NULL
well	NULL
as	NULL
its	NULL
possible	NULL
therapeutic	NULL
use	NULL
as	NULL
an	NULL
adjuvant	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Animals	NULL
.	NULL

-	NULL
Female	NULL
C57BL/6	NULL
,	NULL
C57BL/6	NULL
IFN-y~'~-	NULL
,	NULL
C57BL/6	NULL
IL-4~	NULL
``	NULL
~	NULL
mice	NULL
,	NULL
and	NULL
5CC7	NULL
B10.A/Ai	NULL
recombination	NULL
activating	NULL
gene	NULL
(	NULL
RAG	NULL
)	NULL
-2~	NULL
``	NULL
~	NULL
mice	NULL
expressing	NULL
a	NULL
TCR	NULL
transgene	NULL
specific	NULL
for	NULL
cytochrome	NULL
C	NULL
were	NULL
obtained	NULL
from	NULL
Taconic	NULL
Farms	NULL
and	NULL
used	NULL
at	NULL
4-8	NULL
wk	NULL
of	NULL
age	NULL
.	NULL

Female	NULL
BALB/c	NULL
and	NULL
Stat6~'~	NULL
(	NULL
C129S2-Stat6	NULL
)	NULL
mice	NULL
were	NULL
obtained	NULL
from	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
.	NULL

All	NULL
animals	NULL
were	NULL
housed	NULL
under	NULL
specific	NULL
pathogen-free	NULL
conditions	NULL
and	NULL
provided	NULL
food	NULL
and	NULL
water	NULL
ad	NULL
libitum	NULL
.	NULL

Animals	NULL
were	NULL
maintained	NULL
according	NULL
to	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Animal	NULL
Care	NULL
Guidelines	NULL
.	NULL

Cell	NULL
Lines	NULL
.	NULL

-	NULL
Short-term	NULL
polarized	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
as	NULL
follows	NULL
:	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
lymph	NULL
nodes	NULL
of	NULL
5CC7	NULL
RAG-2~	NULL
``	NULL
~	NULL
mice	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
FITC-labeled	NULL
anti-B220	NULL
,	NULL
anti-CD8	NULL
,	NULL
and	NULL
anti-I-A*	NULL
,	NULL
followed	NULL
by	NULL
anti-FITC	NULL
magnetic	NULL
separation	NULL
.	NULL

Purity	NULL
of	NULL
CD4*	NULL
population	NULL
was	NULL
confirmed	NULL
by	NULL
FACS®	NULL
analysis	NULL
.	NULL

CD4+*	NULL
T	NULL
cells	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
milliliter	NULL
)	NULL
were	NULL
stimulated	NULL
in	NULL
vitro	NULL
for	NULL
4-5	NULL
d	NULL
with	NULL
T	NULL
cell-depleted	NULL
,	NULL
irradiated	NULL
B10.A	NULL
APCs	NULL
(	NULL
10	NULL
%	NULL
cells	NULL
per	NULL
milliliter	NULL
)	NULL
and	NULL
1	NULL
pM	NULL
cytochrome	NULL
C	NULL
peptide	NULL
in	NULL
IL-2-supplemented	NULL
media	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
B-mercaptocethanol	NULL
.	NULL

To	NULL
establish	NULL
Th1	NULL
lines	NULL
,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
and	NULL
anti-IL-4	NULL
(	NULL
10	NULL
pg/ml	NULL
11B11	NULL
)	NULL
were	NULL
added	NULL
to	NULL
cultures	NULL
.	NULL

For	NULL
Th2	NULL
lines	NULL
,	NULL
IL-4	NULL
(	NULL
1,000	NULL
U/ml	NULL
)	NULL
,	NULL
anti-IL-12	NULL
(	NULL
10	NULL
pg/ml	NULL
€17.8	NULL
)	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
(	NULL
10	NULL
g/ml	NULL
XMG	NULL
1.2	NULL
)	NULL
were	NULL
added	NULL
.	NULL

Th	NULL
``	NULL
null	NULL
``	NULL
cells	NULL
were	NULL
established	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-IL-12	NULL
,	NULL
anti-IL-4	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
antibodies	NULL
.	NULL

After	NULL
4-5	NULL
d	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
fresh	NULL
IL-2	NULL
media	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
splenic	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
C57BL/6	NULL
or	NULL
IFN-y~'~	NULL
mice	NULL
were	NULL
cultured	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
milliliter	NULL
)	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
5	NULL
pg/ml	NULL
2C11	NULL
;	NULL
BD	NULL
PharMingen	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
with	NULL
or	NULL
without	NULL
rIL-12	NULL
,	NULL
fIL-18	NULL
,	NULL
1IL-4	NULL
,	NULL
rIL-10	NULL
,	NULL
rh	NULL
for	NULL
48	NULL
h.	NULL
Cells	NULL
were	NULL
washed	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
fresh	NULL
IL-2	NULL
media	NULL
(	NULL
with	NULL
or	NULL
without	NULL
fresh	NULL
cytokine	NULL
added	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h	NULL
before	NULL
FACS®	NULL
analysis	NULL
.	NULL

Flow	NULL
Cytometry	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
placed	NULL
(	NULL
1-2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
into	NULL
individual	NULL
wells	NULL
of	NULL
a	NULL
96-well	NULL
V-bottomed	NULL
Costar	NULL
plate	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
first	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
jug	NULL
of	NULL
rat	NULL
anti-mouse	NULL
CD16/CD32	NULL
(	NULL
Fc	NULL
block	NULL
;	NULL
BD	NULL
PharMingen	NULL
)	NULL
to	NULL
block	NULL
nonspecific	NULL
binding	NULL
of	NULL
goat	NULL
Ig/anti-IL-18Ra	NULL
antibody	NULL
to	NULL
Fc	NULL
receptors	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
either	NULL
1	NULL
pg	NULL
of	NULL
goat	NULL
IgG	NULL
or	NULL
1	NULL
jug	NULL
of	NULL
goat	NULL
anti-murine	NULL
IL-18Ra	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
diluted	NULL
in	NULL
PBS	NULL
containing	NULL
5	NULL
%	NULL
normal	NULL
mouse	NULL
serum	NULL
(	NULL
PBS-NMS	NULL
)	NULL
.	NULL

Anti-IL-18Ra	NULL
is	NULL
an	NULL
affinity-purified	NULL
,	NULL
polyclonal	NULL
goat-specific	NULL
IgG	NULL
antibody	NULL
that	NULL
recognizes	NULL
the	NULL
extracellular	NULL
domain	NULL
(	NULL
peptide	NULL
19-326	NULL
)	NULL
of	NULL
recombinant	NULL
murine	NULL
IL-18Ra	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
respective	NULL
antibody	NULL
for	NULL
30	NULL
min	NULL
,	NULL
4°C	NULL
,	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
incubated	NULL
in	NULL
PBS-NMS	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
SP-biotinylated	NULL
mouse	NULL
anti-goat	NULL
IgG	NULL
(	NULL
H	NULL
plus	NULL
L	NULL
)	NULL
diluted	NULL
in	NULL
PBS-NMS	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
)	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
washed	NULL
two	NULL
times	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
streptavidin-PFE	NULL
(	NULL
BD	NULL
PharMingen	NULL
)	NULL
diluted	NULL
in	NULL
PBS	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
4°C	NULL
,	NULL
FITC-labeled	NULL
anti-CD4	NULL
(	NULL
BD	NULL
PharMingen	NULL
)	NULL
was	NULL
added	NULL
directly	NULL
to	NULL
wells	NULL
for	NULL
an	NULL
additional	NULL
20-min	NULL
incubation	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
again	NULL
washed	NULL
two	NULL
times	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
.	NULL

7-AAD	NULL
was	NULL
added	NULL
immediately	NULL
before	NULL
FACS®	NULL
analysis	NULL
to	NULL
exclude	NULL
dead	NULL
cells	NULL
from	NULL
analysis	NULL
.	NULL

Analysis	NULL
was	NULL
performed	NULL
using	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
difference	NULL
(	NULL
A	NULL
)	NULL
between	NULL
the	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
MFI	NULL
)	NULL
of	NULL
the	NULL
positive	NULL
stain	NULL
(	NULL
anti-IL-18Ra	NULL
)	NULL
and	NULL
the	NULL
MFI	NULL
of	NULL
the	NULL
negative	NULL
control	NULL
(	NULL
goat	NULL
Ig	NULL
)	NULL
.	NULL

Cytokine	NULL
Assays	NULL
.	NULL

T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
primed	NULL
in	NULL
vitro	NULL
for	NULL
4-7	NULL
d	NULL
under	NULL
various	NULL
polarizing	NULL
conditions	NULL
were	NULL
resuspended	NULL
in	NULL
fresh	NULL
IL-2	NULL
medium	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
milliliter	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
24-well	NULL
plates	NULL
for	NULL
48	NULL
h	NULL
with	NULL
10	NULL
ng/ml	NULL
IL-12	NULL
,	NULL
30	NULL
ng/ml	NULL
IL-18	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Cell-free	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
levels	NULL
of	NULL
IFN-y	NULL
determined	NULL
by	NULL
ELISA	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
primed	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
either	NULL
immobilized	NULL
anti-CD3	NULL
(	NULL
5	NULL
pg/ml	NULL
2C11	NULL
;	NULL
BD	NULL
PharMingen	NULL
)	NULL
or	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
as	NULL
above	NULL
)	NULL
for	NULL
6-8	NULL
h	NULL
,	NULL
and	NULL
monensin	NULL
was	NULL
added	NULL
for	NULL
the	NULL
final	NULL
4	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
permeabilized	NULL
with	NULL
saponin/PBS	NULL
buffer	NULL
,	NULL
then	NULL
stained	NULL
for	NULL
intracellular	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
.	NULL

Results	NULL
Naive	NULL
T	NULL
Cells	NULL
Express	NULL
the	NULL
IL-18Ra	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
studies	NULL
which	NULL
only	NULL
detected	NULL
the	NULL
IL-18Ra	NULL
on	NULL
fully	NULL
differentiated	NULL
Th1	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
,	NULL
a	NULL
majority	NULL
(	NULL
82	NULL
+	NULL
2	NULL
%	NULL
)	NULL
of	NULL
both	NULL
CD4*	NULL
and	NULL
CD8	NULL
#	NULL
+	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
C57BL/6	NULL
mice	NULL
were	NULL
reactive	NULL
by	NULL
FACS®	NULL
analysis	NULL
with	NULL
the	NULL
polyclonal	NULL
antibody	NULL
to	NULL
recombinant	NULL
IL-18Ra	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
multiple	NULL
experiments	NULL
(	NULL
#	NULL
=	NULL
5	NULL
)	NULL
of	NULL
this	NULL
type	NULL
the	NULL
AMFI	NULL
of	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
on	NULL
freshly	NULL
explanted	NULL
CD4+*	NULL
T	NULL
cells	NULL
was	NULL
143	NULL
+	NULL
11	NULL
.	NULL

CD4¢*	NULL
and	NULL
CD8+*	NULL
T	NULL
cells	NULL
in	NULL
lymph	NULL
node	NULL
expressed	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
spleen	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
detected	NULL
high	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
on	NULL
mature	NULL
CD4*	NULL
and	NULL
CD8*	NULL
single	NULL
positive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
while	NULL
CD4*CD8+*	NULL
double	NULL
positive	NULL
thymocytes	NULL
expressed	NULL
rela-	NULL
144	NULL
__	NULL
Regulation	NULL
of	NULL
IL-18	NULL
Receptor	NULL
Expression	NULL
tively	NULL
low	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
appears	NULL
to	NULL
be	NULL
acquired	NULL
during	NULL
the	NULL
process	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
was	NULL
independent	NULL
of	NULL
either	NULL
IL-12	NULL
or	NULL
IFN-y	NULL
as	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
on	NULL
CD4*	NULL
cells	NULL
from	NULL
IL-12~	NULL
``	NULL
~	NULL
or	NULL
IFN-y~	NULL
``	NULL
~-	NULL
mice	NULL
was	NULL
identical	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
other	NULL
cell	NULL
types	NULL
revealed	NULL
low	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
on	NULL
B220¢+	NULL
splenic	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
D	NULL
)	NULL
,	NULL
while	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
was	NULL
found	NULL
on	NULL
NK1.1*	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
E	NULL
)	NULL
.	NULL

We	NULL
consistently	NULL
identified	NULL
a	NULL
small	NULL
population	NULL
(	NULL
~6-10	NULL
%	NULL
)	NULL
of	NULL
splenic	NULL
CD4*	NULL
cells	NULL
that	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
IL-	NULL
A	NULL
M1i=	NULL
A156	NULL
M2=	NULL
A1072	NULL
Counts	NULL
0	NULL
20	NULL
40	NULL
60	NULL
$	NULL
0	NULL
100	NULL
®	NULL
7	NULL
9	NULL
j	NULL
M1=	NULL
A136	NULL
28-7	NULL
J.	NULL
is	NULL
)	NULL
``	NULL
Af	NULL
\	NULL
|	NULL
o~	NULL
kt	NULL
\	NULL
53,4	NULL
h.	NULL
©	NULL
``	NULL
'	NULL
_	NULL
‘	NULL
1'.n	NULL
mbr	NULL
.	NULL

cress	NULL
cot	NULL
10°	NULL
ao	NULL
``	NULL
40	NULL
%	NULL
408	NULL
105	NULL
24	NULL
fr	NULL
AlS3	NULL
73	NULL
I	NULL
>	NULL
“	NULL
Ely	NULL
``	NULL
*	NULL
1x	NULL
\	NULL
d	NULL
``	NULL
n	NULL
no	NULL
ps	NULL
Counts	NULL
us	NULL
!	NULL

(	NULL
=	NULL
]	NULL
8	NULL
&	NULL
dP	NULL
#	NULL
o	NULL
£10	NULL
a	NULL
&	NULL
#	NULL
i=l	NULL
L	NULL
ai	NULL
,	NULL
%	NULL
o	NULL
{	NULL
10	NULL
%	NULL
aol	NULL
aot	NULL
ant	NULL
ao	NULL
``	NULL
IL-18Ro-PE	NULL
Figure	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
IL-18Ra	NULL
«	NULL
on	NULL
cells	NULL
from	NULL
naive	NULL
mice	NULL
:	NULL
splenic	NULL
CD4*	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CD8+	NULL
(	NULL
C	NULL
)	NULL
T	NULL
cells	NULL
from	NULL
C57BL/6	NULL
mice	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
5CC7	NULL
TCR	NULL
transgenic	NULL
mice	NULL
on	NULL
RAG-2~~	NULL
background	NULL
(	NULL
B	NULL
)	NULL
,	NULL
B220+	NULL
cells	NULL
(	NULL
D	NULL
)	NULL
,	NULL
and	NULL
NK1.1*	NULL
cells	NULL
(	NULL
E	NULL
)	NULL
from	NULL
spleens	NULL
of	NULL
C57BL/6	NULL
mice	NULL
.	NULL

Spleen	NULL
cells	NULL
were	NULL
pooled	NULL
from	NULL
naive	NULL
mice	NULL
and	NULL
analyzed	NULL
for	NULL
expression	NULL
by	NULL
FACS®	NULL
.	NULL

Analysis	NULL
was	NULL
gated	NULL
on	NULL
7-AAD~	NULL
cells	NULL
only	NULL
(	NULL
i.e	NULL
.	NULL

viable	NULL
cells	NULL
)	NULL
.	NULL

Numbers	NULL
in	NULL
parentheses	NULL
refer	NULL
to	NULL
the	NULL
difference	NULL
(	NULL
A	NULL
)	NULL
between	NULL
the	NULL
MFI	NULL
of	NULL
the	NULL
positive	NULL
stain	NULL
and	NULL
the	NULL
MFI	NULL
of	NULL
the	NULL
isotype	NULL
(	NULL
negative	NULL
)	NULL
stain	NULL
.	NULL

145	NULL
Smeltz	NULL
et	NULL
al	NULL
.	NULL

18Ra	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
M2	NULL
,	NULL
MFI	NULL
1,072	NULL
+	NULL
286	NULL
)	NULL
.	NULL

This	NULL
IL-18Ra®	NULL
population	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
spleens	NULL
of	NULL
5CC7	NULL
TCR	NULL
transgenic	NULL
mice	NULL
on	NULL
a	NULL
RAG-2~	NULL
``	NULL
~	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
arrow	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
CD4*	NULL
IL-18Ra®	NULL
``	NULL
``	NULL
population	NULL
in	NULL
the	NULL
former	NULL
could	NULL
be	NULL
a	NULL
population	NULL
of	NULL
previously	NULL
activated/memory	NULL
T	NULL
cells	NULL
or	NULL
CD4*NK1.1+*	NULL
T	NULL
cells	NULL
.	NULL

Further	NULL
analyses	NULL
revealed	NULL
the	NULL
majority	NULL
(	NULL
~90	NULL
%	NULL
)	NULL
of	NULL
CD4*	NULL
IL-18Ra	NULL
``	NULL
cells	NULL
are	NULL
NK1.1~	NULL
and	NULL
express	NULL
markers	NULL
typically	NULL
associated	NULL
with	NULL
memory/acti-vated	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
distinct	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
IL-18Ra	NULL
'	NULL
``	NULL
*	NULL
and	NULL
IL-18Ra	NULL
``	NULL
)	NULL
can	NULL
be	NULL
detected	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
spleens	NULL
from	NULL
normal	NULL
animals	NULL
.	NULL

Stimulation	NULL
with	NULL
IL-12	NULL
or	NULL
IL-18	NULL
Alone	NULL
Does	NULL
Not	NULL
Lead	NULL
to	NULL
Upregulation	NULL
of	NULL
IL-18Ra	NULL
on	NULL
CD4*	NULL
IL-18Ra	NULL
&	NULL
``	NULL
®	NULL
T	NULL
Cells	NULL
,	NULL
Previous	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
IL-12	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCR	NULL
stimulation	NULL
was	NULL
capable	NULL
of	NULL
inducing	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
,	NULL
thus	NULL
enabling	NULL
IL-18	NULL
to	NULL
synergize	NULL
with	NULL
IL-12	NULL
to	NULL
enhance	NULL
IFN-y	NULL
production	NULL
(	NULL
23	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
effects	NULL
of	NULL
cytokines	NULL
on	NULL
IL-18Ra	NULL
expression	NULL
,	NULL
we	NULL
cultured	NULL
spleen	NULL
cells	NULL
from	NULL
normal	NULL
C57BL/6	NULL
mice	NULL
for	NULL
96	NULL
h	NULL
in	NULL
IL-2-containing	NULL
media	NULL
alone	NULL
or	NULL
in	NULL
IL-2-containing	NULL
media	NULL
supplemented	NULL
with	NULL
either	NULL
IL-12	NULL
or	NULL
IL-18	NULL
.	NULL

Preliminary	NULL
studies	NULL
demonstrated	NULL
that	NULL
IL-2	NULL
was	NULL
required	NULL
to	NULL
maintain	NULL
adequate	NULL
viability	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Culture	NULL
with	NULL
IL-2	NULL
alone	NULL
led	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
IL-18Ra	NULL
expression	NULL
on	NULL
CD4*	NULL
IL-18Ro*	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
M1	NULL
,	NULL
MFI	NULL
143	NULL
+	NULL
21	NULL
;	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
M1	NULL
,	NULL
MFI	NULL
94	NULL
+	NULL
15	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
IL-18Ra	NULL
on	NULL
the	NULL
subpopulation	NULL
of	NULL
IL-18Ra	NULL
``	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
M2	NULL
,	NULL
MFI	NULL
1,088	NULL
+	NULL
109	NULL
;	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
M2	NULL
,	NULL
MFI	NULL
1,072	NULL
+	NULL
286	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
culture	NULL
in	NULL
IL-2	NULL
alone	NULL
did	NULL
result	NULL
in	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
IL-18Ra®	NULL
population	NULL
from	NULL
6-10	NULL
%	NULL
to	NULL
~20-40	NULL
%	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
96-h	NULL
culture	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
A	NULL
and	NULL
2	NULL
A	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
presumably	NULL
reflects	NULL
the	NULL
preferential	NULL
expansion	NULL
of	NULL
previously	NULL
activated/memory	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Slight	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
on	NULL
the	NULL
CD4*	NULL
IL-18Ra'*	NULL
cells	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
(	NULL
MFI	NULL
102	NULL
+	NULL
12	NULL
)	NULL
,	NULL
but	NULL
not	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B-D	NULL
,	NULL
M1	NULL
,	NULL
MFI	NULL
88	NULL
+	NULL
13	NULL
)	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
the	NULL
minor	NULL
population	NULL
of	NULL
CD4*	NULL
IL-18Ra	NULL
``	NULL
cells	NULL
upregulated	NULL
IL-18Ra	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
M2	NULL
,	NULL
MFI	NULL
2,425	NULL
+	NULL
1,074	NULL
)	NULL
,	NULL
but	NULL
not	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
,	NULL
M2	NULL
,	NULL
MFI	NULL
1,029	NULL
+	NULL
171	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
primary	NULL
effects	NULL
of	NULL
IL-12	NULL
on	NULL
freshly	NULL
explanted	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
normal	NULL
animals	NULL
appear	NULL
to	NULL
be	NULL
via	NULL
upregulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
on	NULL
the	NULL
minor	NULL
population	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
that	NULL
already	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
this	NULL
receptor	NULL
and	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

IL-12	NULL
in	NULL
Concert	NULL
with	NULL
TCR	NULL
Stimulation	NULL
Induces	NULL
Upregulation	NULL
of	NULL
IL-18Ra	NULL
Expression	NULL
on	NULL
CD4*	NULL
T	NULL
Cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
TCR	NULL
stimulation	NULL
on	NULL
IL-18Ra	NULL
expression	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
naive	NULL
C57BL/6	NULL
mice	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
d	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
in	NULL
IL-2-containing	NULL
media	NULL
,	NULL
with	NULL
or	NULL
without	NULL
IL-12/IL-18	NULL
.	NULL

After	NULL
2	NULL
d	NULL
in	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
placed	NULL
into	NULL
fresh	NULL
IL-2	NULL
media	NULL
with	NULL
fresh	NULL
cytokines	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
d.	NULL
This	NULL
two-step	NULL
culture	NULL
system	NULL
was	NULL
used	NULL
because	NULL
significant	NULL
apoptosis	NULL
was	NULL
observed	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
4	NULL
d	NULL
on	NULL
plate-bound	NULL
anti-CD3	NULL
.	NULL

IL-18Ra	NULL
expression	NULL
was	NULL
detected	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
the	NULL
A	NULL
&	NULL
B	NULL
.	NULL

A	NULL
M1=A74	NULL
87	NULL
u*	NULL
f\	NULL
M2=A936	NULL
ad	NULL
$	NULL
s	NULL
=	NULL
\	NULL
§	NULL
{	NULL
/*	NULL
883	NULL
a	NULL
,	NULL
u	NULL
10°	NULL
ao	NULL
!	NULL

ast	NULL
408	NULL
0°	NULL
j	NULL
5	NULL
C	NULL
:	NULL
D	NULL
:	NULL
i	NULL
MI1=A73	NULL
s	NULL
g	NULL
l	NULL
M2=A803	NULL
foe	NULL
38	NULL
l	NULL
+IL-18	NULL
__	NULL
$	NULL
8	NULL
210°	NULL
10	NULL
``	NULL
io	NULL
``	NULL
io	NULL
``	NULL
do	NULL
level	NULL
of	NULL
expression	NULL
was	NULL
consistently	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
on	NULL
freshly	NULL
explanted	NULL
CD4¢*	NULL
T	NULL
cells	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
with	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
and	NULL
CD4¢*	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
IL-2	NULL
alone	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
M1	NULL
with	NULL
Figs	NULL
.	NULL

3	NULL
A	NULL
and	NULL
1	NULL
A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-12	NULL
to	NULL
anti-CD3-stimulated	NULL
cultures	NULL
led	NULL
to	NULL
marked	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
,	NULL
while	NULL
the	NULL
addition	NULL
of	NULL
IL-18	NULL
alone	NULL
did	NULL
not	NULL
result	NULL
in	NULL
enhanced	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

IL-18	NULL
did	NULL
synergize	NULL
with	NULL
IL-12	NULL
to	NULL
enhance	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
D	NULL
)	NULL
.	NULL

Resting	NULL
CD4¢*	NULL
T	NULL
cells	NULL
failed	NULL
to	NULL
produce	NULL
IFN-y	NULL
on	NULL
exposure	NULL
to	NULL
IL-12	NULL
,	NULL
IL-18	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
IL-12/IL-18	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
after	NULL
anti-CD3	NULL
induced	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
large	NULL
amounts	NULL
of	NULL
IFN-y	NULL
were	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
IL-12/IL-18	NULL
irrespective	NULL
of	NULL
the	NULL
priming	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
E-H	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
the	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
seen	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
IL-12	NULL
correlated	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
IL-18	NULL
to	NULL
induce	NULL
IFN-y	NULL
production	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
F	NULL
and	NULL
H	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
primed	NULL
with	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
E	NULL
)	NULL
or	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
G	NULL
)	NULL
did	NULL
not	NULL
produce	NULL
detectable	NULL
IFN-y	NULL
when	NULL
cultured	NULL
with	NULL
IL-18	NULL
alone	NULL
.	NULL

Regulation	NULL
of	NULL
IL-18Ra	NULL
Expression	NULL
by	NULL
IFN-y	NULL
.	NULL

-	NULL
As	NULL
IFN-y	NULL
is	NULL
induced	NULL
by	NULL
IL-12	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
IL-12-mediated	NULL
upregulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
«	NULL
was	NULL
secondary	NULL
to	NULL
IFN-y	NULL
production	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
stimulated	NULL
T	NULL
cells	NULL
from	NULL
IFN-y~'~	NULL
mice	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
.	NULL

After	NULL
4	NULL
d	NULL
of	NULL
culture	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
IFN-y~	NULL
``	NULL
~-	NULL
mice	NULL
expressed	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
that	NULL
were	NULL
similar	NULL
to	NULL
wild-type	NULL
C57BL/6	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
mere	NULL
absence	NULL
of	NULL
IFN-y	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
IL-12-dependent	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
was	NULL
severely	NULL
impaired	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IFN-y	NULL
.	NULL

A	NULL
majority	NULL
of	NULL
CD4+*	NULL
T	NULL
cells	NULL
from	NULL
IFN-y~'~	NULL
upregulate	NULL
IL-18Ra	NULL
expression	NULL
when	NULL
cultured	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-12	NULL
(	NULL
M1	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IFN-y	NULL
to	NULL
these	NULL
cultures	NULL
restored	NULL
IL-12-driven	NULL
upregulation	NULL
of	NULL
mice	NULL
failed	NULL
to	NULL
146	NULL
IL-18Ro-PE	NULL
M1=A95	NULL
M2=A1624	NULL
7	NULL
wal	NULL
+IL-12	NULL
108	NULL
-	NULL
10	NULL
``	NULL
MI1=A102	NULL
Figure	NULL
2	NULL
.	NULL

Stimulation	NULL
with	NULL
IL-12	NULL
or	NULL
_	NULL
IL-18	NULL
alone	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
upregula-M2=A1655	NULL
tion	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
on	NULL
CD4*	NULL
cells	NULL
.	NULL

Spleen	NULL
cells	NULL
from	NULL
+IL-12	NULL
C57BL/6	NULL
mice	NULL
were	NULL
cultured	NULL
for	NULL
96	NULL
h	NULL
+IL-18	NULL
in	NULL
IL-2	NULL
media	NULL
(	NULL
A	NULL
)	NULL
supplemented	NULL
with	NULL
20	NULL
ng/ml	NULL
IL-12	NULL
(	NULL
B	NULL
)	NULL
,	NULL
20	NULL
ng/ml	NULL
IL-18	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
harvested	NULL
and	NULL
analyzed	NULL
for	NULL
IL-18Ra	NULL
expression	NULL
by	NULL
FACS®	NULL
.	NULL

1	NULL
100	NULL
+IL-12	NULL
10	NULL
1	NULL
1	NULL
1	NULL
ng/ml	NULL
IFNY	NULL
100	NULL
+IL-18	NULL
0	NULL
o	NULL
mg	NULL
14	NULL
``	NULL
M4	NULL
-*-	NULL
k	NULL
10	NULL
10	NULL
10	NULL
10	NULL
``	NULL
10	NULL
p	NULL
:	NULL
_o	NULL
f	NULL
IL-18Ro-PE	NULL
=	NULL
pl	NULL
P	NULL
@	NULL
a	NULL
+	NULL
ca	NULL
in	NULL
fan	NULL
mat	NULL
Figure	NULL
3	NULL
.	NULL

_	NULL
IL-12	NULL
in	NULL
concert	NULL
with	NULL
TCR	NULL
stimulation	NULL
results	NULL
in	NULL
upregula-	NULL
tion	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
C57BL/6	NULL
mice	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
for	NULL
2	NULL
d	NULL
in	NULL
IL-2	NULL
alone	NULL
(	NULL
A	NULL
and	NULL
E	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-2	NULL
and	NULL
IL-12	NULL
(	NULL
B	NULL
and	NULL
F	NULL
)	NULL
,	NULL
IL-18	NULL
(	NULL
C	NULL
and	NULL
G	NULL
)	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
D	NULL
and	NULL
H	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
placed	NULL
into	NULL
fresh	NULL
IL-2	NULL
media	NULL
with	NULL
or	NULL
without	NULL
cytokines	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
d.	NULL
Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
stained	NULL
for	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
(	NULL
A-D	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
either	NULL
IL-12	NULL
,	NULL
IL-18	NULL
,	NULL
or	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
for	NULL
48	NULL
h	NULL
and	NULL
supernatants	NULL
tested	NULL
for	NULL
IFN-y	NULL
production	NULL
(	NULL
E-H	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
IL-18	NULL
Receptor	NULL
Expression	NULL
A	NULL
WT	NULL
B	NULL
IFN-y	NULL
C	NULL
&	NULL
e	NULL
5	NULL
Ao	NULL
2	NULL
M1	NULL
5	NULL
®	NULL
Bi	NULL
j	NULL
a43|	NULL
=	NULL
#	NULL
``	NULL
Fd	NULL
i	NULL
¥	NULL
£0	NULL
50	NULL
£0	NULL
|	NULL
c	NULL
3	NULL
®	NULL
cao	NULL
8s	NULL
&	NULL
awn	NULL
10	NULL
)	NULL
9	NULL
an	NULL
o	NULL
``	NULL
10°	NULL
40	NULL
``	NULL
102	NULL
103	NULL
10	NULL
``	NULL
E	NULL
F	NULL
&	NULL
&	NULL
-	NULL
o	NULL
g	NULL
:	NULL
Ao	NULL
m	NULL
3	NULL
|_|	NULL
M1	NULL
M1	NULL
8	NULL
81	NULL
J	NULL
A38	NULL
&	NULL
A608	NULL
]	NULL
1L-12	NULL
a	NULL
_	NULL
$	NULL
8	NULL
|	NULL
ia	NULL
*+	NULL
#	NULL
5	NULL
+1IL12	NULL
0	NULL
§84	NULL
HFN	NULL
!	NULL

fg	NULL
,	NULL
a~	NULL
So	NULL
M2	NULL
a*	NULL
m2	NULL
|	NULL
IFN-y	NULL
Qo	NULL
hle	NULL
Vo	NULL
a	NULL
]	NULL
in	NULL
°	NULL
im	NULL
!	NULL

mw	NULL
iP	NULL
in	NULL
``	NULL
ik	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10	NULL
``	NULL
10	NULL
IOU	NULL
m1	NULL
102	NULL
$	NULL
03	NULL
104	NULL
IL-18Ro	NULL
&	NULL
-PE	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
IL-12-mediated	NULL
enhancement	NULL
of	NULL
IL-18R	NULL
«	NULL
expression	NULL
is	NULL
IFN-y	NULL
dependent	NULL
.	NULL

Spleen	NULL
cells	NULL
from	NULL
wild-type	NULL
C57BL/6	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
and	NULL
IFN-y	NULL
~~	NULL
(	NULL
B-F	NULL
)	NULL
mice	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
d	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
alone	NULL
,	NULL
or	NULL
with	NULL
IL-2	NULL
and	NULL
IL-12	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
IFN-y	NULL
(	NULL
E	NULL
)	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IFN-y	NULL
(	NULL
F	NULL
)	NULL
.	NULL

After	NULL
2	NULL
d	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
placed	NULL
into	NULL
fresh	NULL
IL-2	NULL
media	NULL
with	NULL
fresh	NULL
cytokine	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
d.	NULL
Cells	NULL
were	NULL
then	NULL
stained	NULL
for	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
.	NULL

IL-18Ra	NULL
;	NULL
however	NULL
,	NULL
IFN-y	NULL
itself	NULL
did	NULL
not	NULL
enhance	NULL
IL-18Ra	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
M1	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
IFN-y	NULL
is	NULL
required	NULL
for	NULL
IL-12-mediated	NULL
upregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
and	NULL
most	NULL
likely	NULL
functions	NULL
by	NULL
inducing/maintaining	NULL
IL-12RB2	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
we	NULL
consistently	NULL
observed	NULL
a	NULL
minor	NULL
population	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
could	NULL
upregulate	NULL
their	NULL
IL-18Ra	NULL
in	NULL
an	NULL
IL-12-dependent	NULL
but	NULL
IFN-y-independent	NULL
fashion	NULL
(	NULL
M2	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
D-F	NULL
)	NULL
.	NULL

We	NULL
suspect	NULL
these	NULL
are	NULL
memory	NULL
T	NULL
cells	NULL
,	NULL
based	NULL
on	NULL
our	NULL
observations	NULL
that	NULL
memory	NULL
cells	NULL
can	NULL
upregulate	NULL
their	NULL
IL-18Ra	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A-D	NULL
)	NULL
.	NULL

IL-4	NULL
in	NULL
Concert	NULL
with	NULL
TCR	NULL
Stimulation	NULL
Induces	NULL
Downregulation	NULL
of	NULL
IL-18Ra	NULL
.	NULL

-	NULL
While	NULL
previous	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
IL-12	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
augment	NULL
IL-18	NULL
responses	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
cytokines	NULL
which	NULL
may	NULL
negatively	NULL
regulate	NULL
IL-18Rax	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
stimulated	NULL
C57BL/6	NULL
CD4+*	NULL
T	NULL
cells	NULL
with	NULL
anti-CD3/IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
or	NULL
TGEF-B	NULL
.	NULL

IL-4	NULL
markedly	NULL
enhanced	NULL
the	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
observed	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
I	NULL
,	NULL
and	NULL
K	NULL
)	NULL
.	NULL

While	NULL
the	NULL
addition	NULL
of	NULL
IL-10	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
TGF-B	NULL
augmented	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
D	NULL
)	NULL
.	NULL

Although	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-10	NULL
expressed	NULL
detectable	NULL
levels	NULL
of	NULL
the	NULL
IL-18Ra	NULL
,	NULL
they	NULL
failed	NULL
to	NULL
secrete	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
F	NULL
and	NULL
G	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
capable	NULL
of	NULL
producing	NULL
significant	NULL
quantities	NULL
of	NULL
IFN-y	NULL
when	NULL
cultured	NULL
with	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
F-H	NULL
)	NULL
.	NULL

Because	NULL
these	NULL
studies	NULL
were	NULL
performed	NULL
without	NULL
concomitant	NULL
neutralization	NULL
of	NULL
IL-12	NULL
and/or	NULL
IFN-y	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
IL-4	NULL
to	NULL
completely	NULL
inhibit	NULL
IFN-y	NULL
induction	NULL
by	NULL
IL-12	NULL
and	NULL
IL-18	NULL
is	NULL
due	NULL
to	NULL
endogenous	NULL
IL-12/IFN-y	NULL
.	NULL

147	NULL
Smeltz	NULL
et	NULL
al	NULL
.	NULL

Because	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-4	NULL
was	NULL
capable	NULL
of	NULL
downregulating	NULL
IL-18Rax	NULL
,	NULL
we	NULL
suspected	NULL
that	NULL
endogenous	NULL
IL-4	NULL
was	NULL
partially	NULL
responsible	NULL
for	NULL
the	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
observed	NULL
with	NULL
anti-CD3	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
added	NULL
cytokine	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothe-sis	NULL
,	NULL
we	NULL
stimulated	NULL
T	NULL
cells	NULL
from	NULL
IL-4~	NULL
``	NULL
~	NULL
mice	NULL
and	NULL
measured	NULL
expression	NULL
.	NULL

When	NULL
compared	NULL
with	NULL
wild-type	NULL
C57BL/6	NULL
mice	NULL
,	NULL
IL-4C	NULL
``	NULL
~	NULL
T	NULL
cells	NULL
expressed	NULL
significantly	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
I	NULL
and	NULL
J	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
before	NULL
stimulation	NULL
were	NULL
comparable	NULL
for	NULL
both	NULL
C5S7BL/6	NULL
and	NULL
IL-4~	NULL
``	NULL
~	NULL
,	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-4	NULL
resulted	NULL
in	NULL
a	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
that	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
wild-type	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
K	NULL
and	NULL
L	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
IL-4	NULL
in	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
.	NULL

Requirement	NULL
for	NULL
Stat6	NULL
in	NULL
Regulation	NULL
of	NULL
IL-18Ra	NULL
Expression	NULL
/	NULL
Function	NULL
on	NULL
CD4*	NULL
T	NULL
Cells	NULL
.	NULL

Because	NULL
IL-4	NULL
signals	NULL
mainly	NULL
via	NULL
Stat6	NULL
,	NULL
we	NULL
determined	NULL
if	NULL
Stat6	NULL
signaling	NULL
was	NULL
required	NULL
for	NULL
IL-4-induced	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
,	NULL
CD4¢*	NULL
T	NULL
cells	NULL
from	NULL
Stat6	NULL
'~	NULL
mice	NULL
expressed	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
(	NULL
AMFI	NULL
=	NULL
208	NULL
)	NULL
compared	NULL
with	NULL
wild-type	NULL
T	NULL
cells	NULL
(	NULL
AMFI	NULL
=	NULL
93	NULL
;	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
endogenous	NULL
Stat6	NULL
signaling	NULL
partially	NULL
contributes	NULL
to	NULL
anti-CD3-induced	NULL
downregulation	NULL
of	NULL
IL-18Rax	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
IL-4~	NULL
``	NULL
~	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
I-K	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
downregulatory	NULL
effects	NULL
of	NULL
IL-4	NULL
seen	NULL
with	NULL
wild-type	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-4	NULL
to	NULL
cultures	NULL
of	NULL
CD4+*	NULL
T	NULL
cells	NULL
from	NULL
Stat6~	NULL
``	NULL
~	NULL
mice	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
E	NULL
)	NULL
indicating	NULL
that	NULL
Stat6	NULL
is	NULL
required	NULL
for	NULL
IL-4-mediated	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
to	NULL
augment	NULL
IL-18Ra	NULL
ex	NULL
E	NULL
g	NULL
2	NULL
.	NULL

~	NULL
T	NULL
T	NULL
T	NULL
F	NULL
sg	NULL
=	NULL
{	NULL
+IL-4	NULL
€	NULL
§	NULL
~	NULL
T	NULL
T	NULL
T	NULL
E	NULL
G	NULL
*s	NULL
s-	NULL
+IL-10	NULL
m	NULL
1-4	NULL
``	NULL
--	NULL
H	NULL
-g	NULL
SF	NULL
+TGF-f	NULL
o	NULL
4	NULL
=	NULL
T	NULL
T	NULL
Tt	NULL
frrms	NULL
1	NULL
t	NULL
so	NULL
10°	NULL
ao	NULL
)	NULL
aot	NULL
qot	NULL
qo	NULL
``	NULL
t	NULL
``	NULL
o	NULL
T	NULL
IL-18Ro-PE	NULL
m	NULL
=	NULL
f	NULL
+	NULL
bm	NULL
+IL-4	NULL
_	NULL
3	NULL
C57BL/6	NULL
K	NULL
=	NULL
Counts	NULL
z*	NULL
10	NULL
)	NULL
10°	NULL
10°	NULL
40	NULL
12	NULL
as	NULL
``	NULL
``	NULL
Tol	NULL
N0	NULL
do	NULL
``	NULL
io	NULL
``	NULL
Figure	NULL
5	NULL
.	NULL

IL-4	NULL
induces	NULL
downregulation	NULL
of	NULL
IL-18R	NULL
«	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
.	NULL

CD4*	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
C57BL/6	NULL
(	NULL
A-I	NULL
and	NULL
K	NULL
)	NULL
or	NULL
IL-4~	NULL
``	NULL
~	NULL
(	NULL
J	NULL
and	NULL
L	NULL
)	NULL
mice	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
d	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
alone	NULL
(	NULL
A	NULL
,	NULL
E	NULL
,	NULL
I	NULL
,	NULL
and	NULL
J	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-2	NULL
and	NULL
IL-4	NULL
(	NULL
B	NULL
,	NULL
F	NULL
,	NULL
K	NULL
,	NULL
and	NULL
L	NULL
)	NULL
,	NULL
IL-10	NULL
(	NULL
C	NULL
and	NULL
G	NULL
)	NULL
,	NULL
or	NULL
TGF-B	NULL
(	NULL
D	NULL
and	NULL
H	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
placed	NULL
into	NULL
fresh	NULL
IL-2	NULL
media	NULL
with	NULL
fresh	NULL
cytokine	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
d.	NULL
Cells	NULL
were	NULL
then	NULL
stained	NULL
for	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
(	NULL
A-D	NULL
and	NULL
I-L	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
IL-12	NULL
,	NULL
IL-18	NULL
,	NULL
or	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
tested	NULL
for	NULL
IFN-y	NULL
production	NULL
.	NULL

pression	NULL
was	NULL
significantly	NULL
enhanced	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Stat6	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
C	NULL
and	NULL
F	NULL
)	NULL
.	NULL

To	NULL
correlate	NULL
the	NULL
differences	NULL
in	NULL
receptor	NULL
expression	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
IL-18	NULL
to	NULL
induce	NULL
IFN-y	NULL
production	NULL
,	NULL
anti-CD3-primed	NULL
T	NULL
cells	NULL
from	NULL
both	NULL
BALB/c	NULL
and	NULL
Statb~'~	NULL
mice	NULL
were	NULL
restimulated	NULL
with	NULL
either	NULL
immobilized	NULL
anti-CD3	NULL
or	NULL
cytokine	NULL
and	NULL
subsequently	NULL
stained	NULL
for	NULL
intracellular	NULL
IFN-y	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
Stat6~'-mice	NULL
produced	NULL
more	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
G-K	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
IL-18-induced	NULL
IFN-y	NULL
production	NULL
was	NULL
significantly	NULL
enhanced	NULL
in	NULL
Staté~'~	NULL
mice	NULL
(	NULL
13	NULL
vs.	NULL
7	NULL
%	NULL
,	NULL
Fig	NULL
.	NULL

6	NULL
J	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
observed	NULL
on	NULL
Stat6b~'~	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IL-4	NULL
and	NULL
Stat6	NULL
are	NULL
critical	NULL
regulators	NULL
of	NULL
both	NULL
IL-18Ra	NULL
expression	NULL
and	NULL
IL-18	NULL
responsiveness	NULL
.	NULL

CD4*	NULL
T	NULL
Cells	NULL
Primed	NULL
under	NULL
Th1	NULL
Conditions	NULL
Upregulate	NULL
IL-18Ra	NULL
.	NULL

Since	NULL
we	NULL
found	NULL
that	NULL
all	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
expressed	NULL
the	NULL
IL-18Rax	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
examine	NULL
the	NULL
ki-netics	NULL
of	NULL
regulation	NULL
of	NULL
expression	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4+*	NULL
T	NULL
cells	NULL
into	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
used	NULL
T	NULL
cells	NULL
from	NULL
5CC7	NULL
transgenic	NULL
mice	NULL
on	NULL
the	NULL
RAG-2~	NULL
``	NULL
~	NULL
background	NULL
to	NULL
minimize	NULL
the	NULL
number	NULL
of	NULL
previously	NULL
activated	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
starting	NULL
population	NULL
.	NULL

Th1	NULL
cells	NULL
were	NULL
generated	NULL
by	NULL
culturing	NULL
purified	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
APCs	NULL
,	NULL
antigen	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
anti-IL-4	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

After	NULL
1	NULL
wk	NULL
in	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
antigen	NULL
and	NULL
APCs	NULL
.	NULL

Intracellular	NULL
cytokine	NULL
staining	NULL
revealed	NULL
that	NULL
45	NULL
%	NULL
of	NULL
1-wk	NULL
(	NULL
1X	NULL
)	NULL
Th1	NULL
cells	NULL
expressed	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

No	NULL
IL-4	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
this	NULL
population	NULL
.	NULL

1-wk	NULL
Th1	NULL
cells	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
before	NULL
restimulation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
)	NULL
,	NULL
but	NULL
these	NULL
levels	NULL
increased	NULL
upon	NULL
stimulation	NULL
with	NULL
APCs	NULL
and	NULL
antigen	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
G	NULL
)	NULL
.	NULL

Upon	NULL
re-stimulation	NULL
,	NULL
Th1	NULL
cells	NULL
secreted	NULL
large	NULL
amounts	NULL
of	NULL
IFN-y	NULL
after	NULL
culture	NULL
with	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
but	NULL
also	NULL
secreted	NULL
significant	NULL
amounts	NULL
of	NULL
IFN-y	NULL
when	NULL
cultured	NULL
with	NULL
IL-18	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
J	NULL
)	NULL
.	NULL

The	NULL
null	NULL
cells	NULL
were	NULL
generated	NULL
by	NULL
priming	NULL
with	NULL
peptide	NULL
,	NULL
APCs	NULL
,	NULL
and	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-IL-4	NULL
,	NULL
anti-IL-12	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
antibodies	NULL
.	NULL

Although	NULL
these	NULL
cells	NULL
proliferated	NULL
vigorously	NULL
when	NULL
restimulated	NULL
with	NULL
peptide	NULL
and	NULL
APCs	NULL
,	NULL
they	NULL
failed	NULL
to	NULL
differentiate	NULL
into	NULL
Th1	NULL
or	NULL
Th2	NULL
cells	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
intracellular	NULL
staining	NULL
for	NULL
IFN-y	NULL
or	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
IL-18Ra	NULL
on	NULL
Th	NULL
null	NULL
cells	NULL
after	NULL
1	NULL
wk	NULL
of	NULL
culture	NULL
and	NULL
restimulation	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
on	NULL
unstimulated	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
,	NULL
E	NULL
and	NULL
H	NULL
,	NULL
and	NULL
1	NULL
A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
neither	NULL
IL-12	NULL
nor	NULL
IFN-y	NULL
is	NULL
required	NULL
for	NULL
maintenance	NULL
of	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
during	NULL
the	NULL
1-wk	NULL
priming	NULL
period	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
obtained	NULL
with	NULL
anti-CD3-stimulated	NULL
T	NULL
cells	NULL
from	NULL
IFN-y~	NULL
``	NULL
~-	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
IL-12~	NULL
``	NULL
~	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
mice	NULL
.	NULL

Interestingly	NULL
,	NULL
Th	NULL
null	NULL
cells	NULL
failed	NULL
to	NULL
produce	NULL
IFN-y	NULL
when	NULL
restimulated	NULL
with	NULL
IL-12	NULL
or	NULL
IL-18	NULL
alone	NULL
,	NULL
but	NULL
did	NULL
respond	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
K	NULL
)	NULL
.	NULL

CD4*	NULL
T	NULL
Cells	NULL
Primed	NULL
under	NULL
Th2	NULL
Conditions	NULL
Rapidly	NULL
Down-regulate	NULL
IL-18Ra	NULL
Expression	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
Th1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
terminally	NULL
differentiated	NULL
Th1	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
dynamics	NULL
of	NULL
IL-18Ra	NULL
during	NULL
Th2	NULL
differentiation	NULL
,	NULL
TCR	NULL
transgenic	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antigen	NULL
,	NULL
APCs	NULL
,	NULL
IL-4	NULL
,	NULL
anti-IL-12	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
.	NULL

After	NULL
1	NULL
wk	NULL
of	NULL
priming	NULL
,	NULL
22	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
expressed	NULL
intracellular	NULL
IL-4	NULL
,	NULL
but	NULL
not	NULL
IFN-y	NULL
,	NULL
when	NULL
restimulated	NULL
with	NULL
antigen	NULL
and	NULL
APCs	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
@	NULL
was	NULL
markedly	NULL
downregulated	NULL
after	NULL
1	NULL
wk	NULL
of	NULL
priming	NULL
under	NULL
Th2	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
F	NULL
and	NULL
I	NULL
)	NULL
.	NULL

More	NULL
impressively	NULL
,	NULL
Th2	NULL
cells	NULL
failed	NULL
to	NULL
secrete	NULL
any	NULL
detectable	NULL
IFN-y	NULL
when	NULL
cultured	NULL
with	NULL
IL-12	NULL
,	NULL
IL-18	NULL
,	NULL
or	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
L	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
signaling	NULL
via	NULL
IL-12	NULL
and	NULL
IL-18	NULL
receptors	NULL
is	NULL
extinguished	NULL
even	NULL
after	NULL
1	NULL
wk	NULL
of	NULL
priming	NULL
under	NULL
Th2	NULL
conditions	NULL
.	NULL

148	NULL
Regulation	NULL
of	NULL
IL-18	NULL
Receptor	NULL
Expression	NULL
WT	NULL
A	NULL
g	NULL
,	NULL
D	NULL
g	NULL
i	NULL
A93	NULL
g	NULL
2	NULL
“	NULL
g	NULL
.	NULL

E	NULL
3s	NULL
9	NULL
.	NULL

*	NULL
T	NULL
j	NULL
w	NULL
10°	NULL
ao	NULL
!	NULL

10	NULL
%	NULL
ao	NULL
``	NULL
10°	NULL
B	NULL
Ce	NULL
{	NULL
s	NULL
»	NULL
io	NULL
A	NULL
as-5G	NULL
/	NULL
s	NULL
+IL4	NULL
o	NULL
4	NULL
k	NULL
!	NULL

0	NULL
%	NULL
3	NULL
J|	NULL
E.	NULL
04	NULL
ag	NULL
©	NULL
{	NULL
heet	NULL
Lt	NULL
-B	NULL
10	NULL
%	NULL
ao	NULL
!	NULL

10°	NULL
aot	NULL
10	NULL
``	NULL
10°	NULL
in	NULL
'	NULL
nt	NULL
ant	NULL
an	NULL
``	NULL
o	NULL
¥	NULL
|	NULL
A331	NULL
¥	NULL
AiGas	NULL
i	NULL
29d	NULL
Egi	NULL
|	NULL
\	NULL
fed	NULL
+IL-12	NULL
(	NULL
so—	NULL
[	NULL
m	NULL
\	NULL
Se	NULL
A	NULL
ﬂ~	NULL
©	NULL
erm	NULL
irs	NULL
bient	NULL
10°	NULL
10	NULL
)	NULL
102	NULL
102	NULL
10	NULL
``	NULL
10	NULL
%	NULL
ao	NULL
``	NULL
aot	NULL
aot	NULL
ao	NULL
``	NULL
IL-18Ro-PE	NULL
IL-18Ro-PE	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Stat6	NULL
is	NULL
required	NULL
for	NULL
IL-4-mediated	NULL
downregulation	NULL
of	NULL
IL-	NULL
18Ra	NULL
expression	NULL
and	NULL
IL-18-induced	NULL
IFN-y	NULL
.	NULL

CD4*	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
BALB/c	NULL
(	NULL
A-C	NULL
and	NULL
G-K	NULL
)	NULL
and	NULL
Staté~'~	NULL
(	NULL
D-F	NULL
and	NULL
G-K	NULL
)	NULL
mice	NULL
were	NULL
stimulated	NULL
for	NULL
two	NULL
d	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
alone	NULL
(	NULL
A	NULL
and	NULL
D	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-2	NULL
and	NULL
IL-4	NULL
(	NULL
B	NULL
and	NULL
E	NULL
)	NULL
or	NULL
IL-12	NULL
(	NULL
C	NULL
and	NULL
F	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
placed	NULL
into	NULL
fresh	NULL
IL-2	NULL
media	NULL
with	NULL
fresh	NULL
cytokine	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
d.	NULL
Cells	NULL
were	NULL
then	NULL
stained	NULL
for	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
from	NULL
BALB/c	NULL
or	NULL
mice	NULL
were	NULL
primed	NULL
for	NULL
7	NULL
d	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
,	NULL
then	NULL
restimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
(	NULL
G	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
I	NULL
and	NULL
K	NULL
)	NULL
,	NULL
or	NULL
IL-18	NULL
(	NULL
J	NULL
and	NULL
K	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
for	NULL
intracellular	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
.	NULL

Discussion	NULL
IL-18	NULL
has	NULL
now	NULL
been	NULL
well	NULL
characterized	NULL
as	NULL
a	NULL
costimulatory	NULL
factor	NULL
for	NULL
IL-12-mediated	NULL
Th1	NULL
differentiation	NULL
.	NULL

IL-18	NULL
may	NULL
mediate	NULL
its	NULL
effects	NULL
directly	NULL
by	NULL
augmentation	NULL
of	NULL
IFN-y	NULL
production	NULL
(	NULL
6	NULL
,	NULL
10	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
or	NULL
by	NULL
enhancement	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-12R	NULL
complex	NULL
,	NULL
thereby	NULL
potentiating	NULL
the	NULL
effects	NULL
of	NULL
IL-12	NULL
(	NULL
25	NULL
)	NULL
.	NULL

While	NULL
many	NULL
studies	NULL
have	NULL
focused	NULL
attention	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-12R	NULL
during	NULL
Th	NULL
cell	NULL
differentiation	NULL
,	NULL
fewer	NULL
have	NULL
focused	NULL
on	NULL
regulation	NULL
of	NULL
the	NULL
IL-18R	NULL
(	NULL
24	NULL
,	NULL
26-29	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
widely	NULL
assumed	NULL
that	NULL
the	NULL
IL-18Ra	NULL
is	NULL
expressed	NULL
only	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
as	NULL
the	NULL
IL-18Ra	NULL
could	NULL
readily	NULL
be	NULL
detected	NULL
on	NULL
fully	NULL
differentiated	NULL
murine	NULL
Th1	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
on	NULL
Th2	NULL
cells	NULL
,	NULL
either	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
or	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
22-24	NULL
,	NULL
26	NULL
)	NULL
.	NULL

We	NULL
have	NULL
used	NULL
a	NULL
polyclonal	NULL
antibody	NULL
prepared	NULL
against	NULL
residues	NULL
19-346	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
IL-18Ra	NULL
and	NULL
were	NULL
readily	NULL
able	NULL
to	NULL
detect	NULL
IL-18Ra	NULL
on	NULL
almost	NULL
all	NULL
CD4*	NULL
and	NULL
CD8+*	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
highly	NULL
likely	NULL
that	NULL
our	NULL
ability	NULL
to	NULL
detect	NULL
the	NULL
IL-18Ra	NULL
on	NULL
naive	NULL
cells	NULL
is	NULL
related	NULL
to	NULL
both	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
antibody	NULL
we	NULL
have	NULL
used	NULL
as	NULL
well	NULL
as	NULL
to	NULL
our	NULL
staining	NULL
protocol	NULL
.	NULL

Although	NULL
the	NULL
IL-18Ra	NULL
was	NULL
expressed	NULL
at	NULL
relatively	NULL
uniform	NULL
levels	NULL
on	NULL
the	NULL
majority	NULL
of	NULL
CD4¢*	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
subpopulation	NULL
of	NULL
unstimulated	NULL
CD4*	NULL
T	NULL
cells	NULL
that	NULL
expressed	NULL
~5-10-fold	NULL
higher	NULL
levels	NULL
of	NULL
receptor	NULL
than	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
CD4*+*	NULL
population	NULL
.	NULL

These	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
activated/	NULL
149	NULL
Smeltz	NULL
et	NULL
al	NULL
.	NULL

anti-CD3	NULL
«	NULL
hus	NULL
a	NULL
=	NULL
«	NULL
_	NULL
4	NULL
&	NULL
21	NULL
nk	NULL
``	NULL
C4	NULL
``	NULL
64	NULL
IL-2	NULL
ps	NULL
2	NULL
,	NULL
4	NULL
%	NULL
~10°	NULL
10	NULL
!	NULL

102	NULL
10°	NULL
105	NULL
I	NULL
w	NULL
=	NULL
co	NULL
+4	NULL
TN	NULL
4	NULL
``	NULL
o	NULL
«	NULL
bit	NULL
3	NULL
<	NULL
WHE	NULL
___	NULL
9	NULL
%	NULL
~10°	NULL
in	NULL
'	NULL
inn	NULL
inm	NULL
49	NULL
J	NULL
v	NULL
%	NULL
s	NULL
%	NULL
<	NULL
}	NULL
``	NULL
C4	NULL
21	NULL
ies	NULL
``	NULL
64	NULL
IL-18	NULL
F	NULL
‘	NULL
E-	NULL
;	NULL
I.	NULL
s	NULL
5	NULL
,	NULL
&	NULL
7	NULL
%	NULL
Ko	NULL
Ti	NULL
#	NULL
®	NULL
ao	NULL
!	NULL

10	NULL
%	NULL
10°	NULL
10+	NULL
hos	NULL
;	NULL
=	NULL
%	NULL
£1	NULL
bq	NULL
t	NULL
IL-12+IL-18	NULL
memory	NULL
T	NULL
cells	NULL
based	NULL
on	NULL
their	NULL
coexpression	NULL
of	NULL
other	NULL
markers	NULL
(	NULL
CD62L®*	NULL
,	NULL
CD44	NULL
``	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
majority	NULL
of	NULL
CD4+*	NULL
IL-18Ra	NULL
'	NULL
``	NULL
*	NULL
cells	NULL
,	NULL
the	NULL
CD4*	NULL
IL-18Ra	NULL
``	NULL
cells	NULL
upregulated	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
«	NULL
on	NULL
culture	NULL
with	NULL
IL-12	NULL
alone	NULL
.	NULL

It	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
IL-12	NULL
alone	NULL
on	NULL
IL-18Ra	NULL
that	NULL
have	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
23	NULL
)	NULL
are	NULL
secondary	NULL
to	NULL
stimulation	NULL
of	NULL
this	NULL
memory	NULL
T	NULL
cell	NULL
population	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
fully	NULL
differentiated	NULL
Th1	NULL
clones	NULL
will	NULL
also	NULL
upregulate	NULL
IL-18Ra	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
produce	NULL
IFN-y	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCR	NULL
ligation	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
truly	NULL
naive	NULL
cells	NULL
can	NULL
respond	NULL
to	NULL
IL-12	NULL
by	NULL
upregulating	NULL
the	NULL
IL-18Rax	NULL
,	NULL
especially	NULL
since	NULL
these	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
the	NULL
IL-12RB2	NULL
subunit	NULL
which	NULL
is	NULL
required	NULL
for	NULL
IL-12	NULL
signaling	NULL
.	NULL

We	NULL
have	NULL
not	NULL
yet	NULL
studied	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
«	NULL
on	NULL
CD8+*	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
it	NULL
also	NULL
remains	NULL
possible	NULL
that	NULL
the	NULL
IL-18Ra	NULL
«	NULL
x	NULL
is	NULL
differentially	NULL
regulated	NULL
on	NULL
CD8+	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
of	NULL
Yoshimoto	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
,	NULL
no	NULL
effort	NULL
was	NULL
made	NULL
to	NULL
separate	NULL
CD4*	NULL
cells	NULL
and	NULL
CD8*	NULL
cells	NULL
.	NULL

Short-term	NULL
culture	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
IL-2	NULL
alone	NULL
led	NULL
to	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
«	NULL
on	NULL
the	NULL
CD4*	NULL
IL-18Ro'~*	NULL
population	NULL
,	NULL
and	NULL
this	NULL
downregulatory	NULL
effect	NULL
was	NULL
further	NULL
po-tentiated	NULL
by	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
showing	NULL
anti-CD3-triggered	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
23	NULL
)	NULL
and	NULL
with	NULL
the	NULL
observations	NULL
of	NULL
Ahn	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
that	NULL
culture	NULL
of	NULL
a	NULL
Th1	NULL
clone	NULL
F	NULL
o	NULL
o	NULL
87	NULL
A28C	NULL
&	NULL
i	NULL
»	NULL
1	NULL
pide	NULL
A2	NULL
o	NULL
oi	NULL
#	NULL
3	NULL
k	NULL
Cq	NULL
Fi	NULL
wo	NULL
j	NULL
281	NULL
#	NULL
84	NULL
£81	NULL
3s	NULL
i	NULL
§°~	NULL
56	NULL
ij	NULL
58i	NULL
ig	NULL
581	NULL
0°	NULL
j	NULL
M	NULL
9	NULL
0	NULL
J	NULL
oj	NULL
o	NULL
j	NULL
=	NULL
oj	NULL
<	NULL
4	NULL
j	NULL
»	NULL
#	NULL
i	NULL
,	NULL
©	NULL
&	NULL
1	NULL
4	NULL
=	NULL
#	NULL
10°	NULL
140	NULL
°	NULL
49	NULL
``	NULL
C	NULL
C	NULL
AT13	NULL
Counts	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
Counts	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Counts	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
E	NULL
:	NULL
omg	NULL
``	NULL
q	NULL
00	NULL
10	NULL
)	NULL
of	NULL
40°	NULL
ao	NULL
IL-18Ro-PE	NULL
W	NULL
0	NULL
4	NULL
10	NULL
10	NULL
``	NULL
40	NULL
``	NULL
10°	NULL
40	NULL
IL-18Ro-PE	NULL
Camag	NULL
(	NULL
-	NULL
hes	NULL
Th	NULL
null	NULL
C	NULL
ME	NULL
”	NULL
?	NULL

22	NULL
%	NULL
Th2	NULL
21	NULL
T	NULL
x	NULL
:	NULL
—	NULL
i	NULL
F	NULL
w=	NULL
C	NULL
xi	NULL
f	NULL
wen	NULL
-	NULL
5/8	NULL
4	NULL
0.9	NULL
%	NULL
=	NULL
7	NULL
..-..	NULL
”	NULL
'	NULL
n..|	NULL
re	NULL
>	NULL
W	NULL
rmrerorree	NULL
10°	NULL
10°	NULL
10	NULL
``	NULL
``	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
105	NULL
IFN-y	NULL
IFN-y	NULL
Figure	NULL
7	NULL
.	NULL

Regulation	NULL
of	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
during	NULL
Th1/Th2	NULL
differentiation	NULL
.	NULL

CD4*	NULL
T	NULL
cells	NULL
from	NULL
5CC7	NULL
trans-	NULL
ng/ml	NULL
IFN-Y	NULL
200	NULL
300	NULL
400	NULL
200	NULL
300	NULL
400	NULL
100	NULL
100	NULL
ND	NULL
genic	NULL
mice	NULL
were	NULL
primed	NULL
with	NULL
irradiated	NULL
APCs	NULL
and	NULL
cytochrome	NULL
C	NULL
under	NULL
Th1	NULL
,	NULL
Th	NULL
null	NULL
,	NULL
or	NULL
Th2	NULL
conditions	NULL
.	NULL

After	NULL
1	NULL
wk	NULL
in	NULL
culture	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
rechallenged	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
and	NULL
then	NULL
stained	NULL
for	NULL
intracellular	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
to	NULL
confirm	NULL
polarization	NULL
of	NULL
T	NULL
cells	NULL
into	NULL
Th1	NULL
(	NULL
A	NULL
)	NULL
,	NULL
Th	NULL
null	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Th-2	NULL
(	NULL
C	NULL
)	NULL
phenotypes	NULL
.	NULL

Alternatively	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
rechallenged	NULL
for	NULL
2	NULL
d	NULL
with	NULL
APCs	NULL
and	NULL
antigen	NULL
,	NULL
but	NULL
2	NULL
0	NULL
IL~12	NULL
_	NULL
]	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
W	NULL
IL-12	NULL
7	NULL
0	NULL
IL~18	NULL
IL~18	NULL
IL-12	NULL
7	NULL
IL~12/IL-18	NULL
IL~12/IL-18	NULL
7	NULL
with	NULL
IL-2	NULL
alone	NULL
also	NULL
led	NULL
to	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
findings	NULL
of	NULL
Yoshimoto	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
culture	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
IL-12	NULL
led	NULL
to	NULL
a	NULL
pronounced	NULL
increase	NULL
in	NULL
IL-18Ra	NULL
«	NULL
expression	NULL
on	NULL
the	NULL
CD4*	NULL
IL-18Ro'~	NULL
population	NULL
.	NULL

A	NULL
possible	NULL
difference	NULL
between	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
and	NULL
those	NULL
of	NULL
others	NULL
is	NULL
that	NULL
in	NULL
our	NULL
4-d	NULL
culture	NULL
system	NULL
with	NULL
anti-CD3	NULL
and	NULL
cytokines	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
for	NULL
only	NULL
the	NULL
first	NULL
2	NULL
d	NULL
to	NULL
reduce	NULL
cell	NULL
death	NULL
as	NULL
the	NULL
result	NULL
of	NULL
repeated	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
.	NULL

Culture	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-18	NULL
failed	NULL
to	NULL
induce	NULL
upregulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
.	NULL

However	NULL
,	NULL
IL-18	NULL
could	NULL
synergize	NULL
with	NULL
IL-12	NULL
to	NULL
induce	NULL
IL-18Ra	NULL
upregulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD3	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
IL-12	NULL
dictates	NULL
IL-18	NULL
responsiveness	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Further	NULL
evidence	NULL
of	NULL
this	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
to	NULL
upregulate	NULL
IL-18Ra	NULL
expression	NULL
is	NULL
abrogated	NULL
in	NULL
Stat4~'~	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
IL-12	NULL
to	NULL
induce	NULL
upregulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
was	NULL
completely	NULL
IFN-y	NULL
dependent	NULL
,	NULL
as	NULL
T	NULL
cells	NULL
from	NULL
150	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokines	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
for	NULL
IL-18Ra	NULL
expression	NULL
both	NULL
before	NULL
(	NULL
D-F	NULL
)	NULL
and	NULL
after	NULL
(	NULL
G-I	NULL
)	NULL
re-challenge	NULL
.	NULL

Also	NULL
,	NULL
Th1	NULL
(	NULL
J	NULL
)	NULL
,	NULL
Th	NULL
null	NULL
(	NULL
K	NULL
)	NULL
,	NULL
or	NULL
Th2	NULL
(	NULL
L	NULL
)	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
the	NULL
indicated	NULL
cytokine	NULL
and	NULL
levels	NULL
of	NULL
IFN-y	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

IL~12/1L-187	NULL
IFN-y~	NULL
``	NULL
~	NULL
mice	NULL
did	NULL
not	NULL
upregulate	NULL
their	NULL
IL-18Ra	NULL
«	NULL
when	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-12	NULL
.	NULL

Although	NULL
reconstitu-tion	NULL
of	NULL
these	NULL
cultures	NULL
with	NULL
IFN-y	NULL
restored	NULL
IL-18Ra	NULL
expression	NULL
,	NULL
IFN-y	NULL
itself	NULL
did	NULL
not	NULL
enhance	NULL
IL-18Ra	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
.	NULL

Thus	NULL
,	NULL
IFN-y	NULL
increases	NULL
T	NULL
cell	NULL
responsiveness	NULL
to	NULL
IL-12	NULL
mostly	NULL
likely	NULL
via	NULL
its	NULL
effects	NULL
on	NULL
induc-tion/maintenance	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
IL-12RB2	NULL
chain	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
IL-18Ra	NULL
on	NULL
resting	NULL
CD4*	NULL
T	NULL
cells	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
factors	NULL
responsible	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
IL-18Ra	NULL
on	NULL
Th2	NULL
clones	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
rapidly	NULL
downregulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
during	NULL
short-term	NULL
stimulation	NULL
of	NULL
naive	NULL
CD4+*	NULL
T	NULL
cells	NULL
with	NULL
anti-CD3	NULL
.	NULL

When	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
primed	NULL
under	NULL
Th2	NULL
conditions	NULL
,	NULL
marked	NULL
downregulation	NULL
was	NULL
seen	NULL
after	NULL
1	NULL
wk	NULL
of	NULL
culture	NULL
and	NULL
after	NULL
3	NULL
wk	NULL
of	NULL
culture	NULL
under	NULL
Th2	NULL
conditions	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
IL-18Ra	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
observable	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
when	NULL
resting	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
IL-4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCR	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
TCR-mediated	NULL
signals	NULL
are	NULL
also	NULL
required	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
IL-18Ra	NULL
expression	NULL
was	NULL
even	NULL
more	NULL
dra-	NULL
Regulation	NULL
of	NULL
IL-18	NULL
Receptor	NULL
Expression	NULL
matic	NULL
when	NULL
T	NULL
cells	NULL
from	NULL
IL-4~	NULL
``	NULL
~	NULL
mice	NULL
were	NULL
used	NULL
.	NULL

IL-4~	NULL
``	NULL
~	NULL
T	NULL
cells	NULL
expressed	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
after	NULL
the	NULL
4-d	NULL
culture	NULL
when	NULL
compared	NULL
with	NULL
wild-type	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-4	NULL
resulted	NULL
in	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
wild-type	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
endogenous	NULL
IL-4	NULL
contributes	NULL
to	NULL
IL-18Ra	NULL
downregulation	NULL
during	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

Further	NULL
support	NULL
for	NULL
the	NULL
role	NULL
of	NULL
IL-4	NULL
in	NULL
negative	NULL
regulation	NULL
of	NULL
IL-18Ra	NULL
is	NULL
that	NULL
Stat6é~'~	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
IL-4	NULL
,	NULL
also	NULL
express	NULL
higher	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
to	NULL
upregulate	NULL
IL-18Rax	NULL
is	NULL
enhanced	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
TGF-B	NULL
to	NULL
either	NULL
anti-CD3	NULL
or	NULL
antigen-primed	NULL
cultures	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

TGF-B	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
others	NULL
to	NULL
inhibit	NULL
IL-4	NULL
production	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
we	NULL
hypothesize	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
IL-4	NULL
production	NULL
by	NULL
TGF-B	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
examining	NULL
the	NULL
cytokine	NULL
requirements	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
IL-18Ra	NULL
during	NULL
Th1/Th2	NULL
differentiation	NULL
,	NULL
we	NULL
have	NULL
also	NULL
examined	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
IL-12	NULL
and	NULL
IL-18	NULL
responsiveness	NULL
.	NULL

Restimulation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
cultured	NULL
for	NULL
4	NULL
d	NULL
with	NULL
anti-CD3	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
but	NULL
not	NULL
either	NULL
cytokine	NULL
alone	NULL
,	NULL
resulted	NULL
in	NULL
production	NULL
of	NULL
large	NULL
amounts	NULL
of	NULL
IFN-y	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
when	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
4	NULL
d	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-12	NULL
,	NULL
they	NULL
produced	NULL
significant	NULL
amounts	NULL
of	NULL
IFN-y	NULL
when	NULL
restimulated	NULL
with	NULL
either	NULL
IL-12	NULL
or	NULL
IL-18	NULL
alone	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
1-wk	NULL
Th1	NULL
cells	NULL
.	NULL

The	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
IL-18	NULL
alone	NULL
correlated	NULL
with	NULL
enhanced	NULL
level	NULL
of	NULL
cell	NULL
surface	NULL
IL-18Ra	NULL
expression	NULL
.	NULL

Although	NULL
CD4*	NULL
T	NULL
cells	NULL
cultured	NULL
with	NULL
anti-CD3	NULL
and	NULL
IL-4	NULL
for	NULL
4	NULL
d	NULL
retained	NULL
their	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
1-wk	NULL
Th2	NULL
cells	NULL
were	NULL
completely	NULL
nonresponsive	NULL
.	NULL

This	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
endogenous	NULL
IL-12	NULL
and	NULL
IFN-y	NULL
in	NULL
Th2-priming	NULL
experiments	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
7	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
regulate	NULL
IL-18-induced	NULL
IFN-y	NULL
production	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
Stat6b~'~	NULL
mice	NULL
,	NULL
which	NULL
secreted	NULL
significantly	NULL
more	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
IL-18/IL-12	NULL
plus	NULL
IL-18	NULL
when	NULL
compared	NULL
with	NULL
controls	NULL
.	NULL

This	NULL
enhanced	NULL
production	NULL
of	NULL
IFN-y	NULL
correlated	NULL
with	NULL
increased	NULL
levels	NULL
of	NULL
IL-18Rax	NULL
expression	NULL
.	NULL

Although	NULL
IFN-y	NULL
production	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
appeared	NULL
to	NULL
correlate	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
IL-18Rax	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
increased	NULL
expression/induction	NULL
of	NULL
IL-18RRB	NULL
accounted	NULL
,	NULL
in	NULL
part	NULL
,	NULL
for	NULL
enhanced	NULL
IFN-y	NULL
production	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
.	NULL

Very	NULL
little	NULL
information	NULL
is	NULL
available	NULL
concerning	NULL
the	NULL
regulation	NULL
of	NULL
IL-18RB	NULL
expression	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Intriguingly	NULL
,	NULL
1-wk	NULL
Th	NULL
null	NULL
cells	NULL
still	NULL
responded	NULL
vigorously	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
by	NULL
producing	NULL
significant	NULL
amounts	NULL
of	NULL
IFN-y	NULL
.	NULL

These	NULL
in	NULL
vitro	NULL
findings	NULL
raise	NULL
a	NULL
number	NULL
of	NULL
questions	NULL
about	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
IL-12	NULL
and	NULL
IL-18	NULL
in	NULL
inducing	NULL
IFN-y	NULL
production	NULL
during	NULL
the	NULL
course	NULL
of	NULL
an	NULL
inflammatory	NULL
response	NULL
in	NULL
vivo	NULL
.	NULL

As	NULL
IL-12	NULL
and	NULL
IL-18	NULL
may	NULL
be	NULL
produced	NULL
by	NULL
different	NULL
cell	NULL
types	NULL
under	NULL
different	NULL
conditions	NULL
,	NULL
one	NULL
possibility	NULL
is	NULL
that	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
an	NULL
IL-12	NULL
rich	NULL
environment	NULL
will	NULL
subsequently	NULL
be	NULL
able	NULL
to	NULL
respond	NULL
by	NULL
pro	NULL
151	NULL
Smeltz	NULL
et	NULL
al	NULL
.	NULL

ducing	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
either	NULL
cytokine	NULL
alone	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
reactivation	NULL
by	NULL
their	NULL
TCR	NULL
.	NULL

Although	NULL
the	NULL
in	NULL
vivo	NULL
equivalent	NULL
of	NULL
our	NULL
Th	NULL
null	NULL
cell	NULL
population	NULL
has	NULL
not	NULL
been	NULL
directly	NULL
demonstrated	NULL
,	NULL
immunization	NULL
of	NULL
mice	NULL
with	NULL
autoan-tigens	NULL
under	NULL
certain	NULL
conditions	NULL
results	NULL
in	NULL
a	NULL
population	NULL
of	NULL
primed	NULL
T	NULL
cells	NULL
that	NULL
only	NULL
produce	NULL
IL-2	NULL
and	NULL
not	NULL
Th1/Th2	NULL
cytokines	NULL
(	NULL
33-34	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
when	NULL
these	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
IL-12	NULL
and	NULL
IL-18	NULL
in	NULL
a	NULL
paracrine	NULL
fashion	NULL
during	NULL
the	NULL
course	NULL
of	NULL
an	NULL
infectious	NULL
insult	NULL
they	NULL
would	NULL
complete	NULL
their	NULL
differentiation	NULL
into	NULL
pathogenic	NULL
Th1	NULL
cells	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
known	NULL
effects	NULL
of	NULL
IL-18	NULL
in	NULL
synergizing	NULL
with	NULL
IL-12	NULL
to	NULL
drive	NULL
Th1	NULL
responses	NULL
,	NULL
recent	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
IL-18	NULL
can	NULL
induce	NULL
Th2-type	NULL
responses	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IgE	NULL
,	NULL
IL-4	NULL
,	NULL
IL-13	NULL
)	NULL
(	NULL
12-15	NULL
)	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
these	NULL
studies	NULL
is	NULL
that	NULL
IL-18	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
production	NULL
by	NULL
basophils	NULL
and	NULL
mast	NULL
cells	NULL
,	NULL
or	NULL
possibly	NULL
CD4¢*	NULL
T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
induction	NULL
of	NULL
IL-4	NULL
production	NULL
by	NULL
IL-18	NULL
in	NULL
NK	NULL
T	NULL
cells	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
(	NULL
35	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
observation	NULL
that	NULL
unstimulated	NULL
CD4+*	NULL
NKT	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-18Ra	NULL
similar	NULL
to	NULL
NK	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
systemic	NULL
production	NULL
of	NULL
IL-4	NULL
may	NULL
facilitate	NULL
the	NULL
priming	NULL
of	NULL
antigen-specific	NULL
CD4*	NULL
Th2	NULL
cells	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
IL-4	NULL
leads	NULL
to	NULL
downregulation	NULL
of	NULL
the	NULL
IL-18Ra	NULL
on	NULL
CD4+*	NULL
T	NULL
cells	NULL
is	NULL
very	NULL
compatible	NULL
with	NULL
such	NULL
a	NULL
model	NULL
,	NULL
as	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
IL-18Ra	NULL
on	NULL
the	NULL
antigen-responsive	NULL
T	NULL
cells	NULL
would	NULL
further	NULL
prevent	NULL
the	NULL
potential	NULL
costimulatory	NULL
effects	NULL
of	NULL
IL-18	NULL
on	NULL
IL-12-mediated	NULL
Th1	NULL
differentiation	NULL
.	NULL

Since	NULL
this	NULL
IL-4-mediated	NULL
downregulation	NULL
of	NULL
IL-18Ra	NULL
was	NULL
only	NULL
observed	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
triggered	NULL
through	NULL
the	NULL
TCR	NULL
,	NULL
bystander	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
resting	NULL
cells	NULL
that	NULL
express	NULL
the	NULL
IL-18Ra	NULL
would	NULL
not	NULL
occur	NULL
.	NULL

Ultimately	NULL
,	NULL
the	NULL
major	NULL
factor	NULL
that	NULL
determines	NULL
whether	NULL
IL-18	NULL
potentiates	NULL
Th1-	NULL
or	NULL
Th2-type	NULL
immune	NULL
responses	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
balance	NULL
between	NULL
IL-12	NULL
and	NULL
IL-4	NULL
in	NULL
the	NULL
microenvironment	NULL
during	NULL
T	NULL
cell	NULL
priming	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
expression	NULL
of	NULL
IL-12	NULL
receptor	NULL
components	NULL
,	NULL
would	NULL
allow	NULL
IL-18	NULL
to	NULL
synergize	NULL
with	NULL
IL-12	NULL
in	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
development	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
specialized	NULL
cell	NULL
types	NULL
capable	NULL
of	NULL
making	NULL
IL-4	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
(	NULL
i.e	NULL
.	NULL

mast	NULL
cells	NULL
)	NULL
would	NULL
favor	NULL
IL-18	NULL
as	NULL
a	NULL
potentiator	NULL
of	NULL
Th2	NULL
responses	NULL
.	NULL

The	NULL
authors	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Dr.	NULL
William	NULL
E.	NULL
Paul	NULL
for	NULL
the	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

Submitted	NULL
:	NULL
6	NULL
March	NULL
2001	NULL
Revised	NULL
:	NULL
1	NULL
June	NULL
2001	NULL
Accepted	NULL
:	NULL
11	NULL
June	NULL
2001	NULL
References	NULL
1	NULL
.	NULL

Okamura	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Tsutsi	NULL
,	NULL
T.	NULL
Komatsu	NULL
,	NULL
M.	NULL
Yutsudo	NULL
,	NULL
T.	NULL
Tanimoto	NULL
,	NULL
K.	NULL
Torigoe	NULL
,	NULL
T.	NULL
Okura	NULL
,	NULL
Y.	NULL
Nukada	NULL
,	NULL
K.	NULL
Hattori	NULL
,	NULL
K.	NULL
Akita	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
new	NULL
cytokine	NULL
that	NULL
induces	NULL
IFN-y	NULL
production	NULL
by	NULL
T-cells	NULL
.	NULL

Nature	NULL
.	NULL

378:88-91	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
2000	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-18	NULL
in	NULL
innate	NULL
immunity	NULL
.	NULL

Cur	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

12:59-63	NULL
.	NULL

3	NULL
.	NULL

Osaki	NULL
,	NULL
T.	NULL
,	NULL
J.-M.	NULL
Peron	NULL
,	NULL
Q.	NULL
Cai	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
P.D	NULL
.	NULL

Robbins	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
M.T	NULL
.	NULL

Lotze	NULL
,	NULL
and	NULL
H.	NULL
Tahara	NULL
.	NULL

1998	NULL
.	NULL

IFN-y-inducing	NULL
factor/IL-18	NULL
administration	NULL
mediates	NULL
IFN-y-	NULL
and	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

IL-12-independent	NULL
antitumor	NULL
effects	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1742-1749.	NULL
.	NULL

Zhang	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
M.H	NULL
.	NULL

Qureshi	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
and	NULL
A.	NULL
Saito	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-12	NULL
(	NULL
IL-12	NULL
)	NULL
and	NULL
IL-18	NULL
synergistically	NULL
induced	NULL
the	NULL
fungicidal	NULL
activity	NULL
of	NULL
murine	NULL
peritoneal	NULL
exudate	NULL
cells	NULL
against	NULL
Crypfococus	NULL
neoformans	NULL
through	NULL
production	NULL
of	NULL
y	NULL
interferon	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

In-fect	NULL
.	NULL

Immunity	NULL
.	NULL

65:3594-3599.	NULL
.	NULL

Tominaga	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Yoshimoto	NULL
,	NULL
K.	NULL
Torigoe	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
K.	NULL
Matsui	NULL
,	NULL
T.	NULL
Hada	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
and	NULL
K.	NULL
Nakanishi	NULL
.	NULL

2000	NULL
.	NULL

IL-12	NULL
synergizes	NULL
with	NULL
IL-18	NULL
or	NULL
IL-1B	NULL
for	NULL
IFN-y	NULL
production	NULL
from	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

12:151-160.	NULL
.	NULL

Kohno	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Kataoka	NULL
,	NULL
T.	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
Suemoto	NULL
,	NULL
L.	NULL
Oka-	NULL
moto	NULL
,	NULL
M.	NULL
Usui	NULL
,	NULL
M.	NULL
Ikeda	NULL
,	NULL
and	NULL
M.	NULL
Kurimoto	NULL
.	NULL

1997	NULL
.	NULL

IFN-y-inducing	NULL
factor	NULL
(	NULL
IGIF	NULL
)	NULL
is	NULL
a	NULL
costimulatory	NULL
factor	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
cells	NULL
and	NULL
exerts	NULL
its	NULL
effect	NULL
independently	NULL
of	NULL
IL-12	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:1541-1550.	NULL
.	NULL

Robinson	NULL
,	NULL
D.	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
A.	NULL
Mui	NULL
,	NULL
F.	NULL
Zonin	NULL
,	NULL
E.	NULL
Murphy	NULL
,	NULL
T.	NULL
Sana	NULL
,	NULL
S.B	NULL
.	NULL

Hartley	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
R.	NULL
Kastelein	NULL
,	NULL
F.	NULL
Basan	NULL
,	NULL
and	NULL
A.	NULL
O'Garra	NULL
.	NULL

1997	NULL
.	NULL

IGIF	NULL
does	NULL
not	NULL
drive	NULL
Th1	NULL
development	NULL
but	NULL
synergizes	NULL
with	NULL
IL-12	NULL
for	NULL
interferon-y	NULL
production	NULL
and	NULL
activates	NULL
IRAK	NULL
and	NULL
NFKB	NULL
.	NULL

Immunity	NULL
.	NULL

7:571-581.	NULL
.	NULL

Stoll	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Jonuleit	NULL
,	NULL
E.	NULL
Schmitt	NULL
,	NULL
G.	NULL
Muller	NULL
,	NULL
H.	NULL
Yamauchi	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
J.	NULL
Knop	NULL
,	NULL
and	NULL
A.H.	NULL
Enk	NULL
.	NULL

1998	NULL
.	NULL

Production	NULL
of	NULL
functional	NULL
IL-18	NULL
by	NULL
different	NULL
subtypes	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
dendritic	NULL
cells	NULL
(	NULL
DC	NULL
)	NULL
:	NULL
DC-derived	NULL
IL-18	NULL
enhances	NULL
IL-12-dependent	NULL
Th1	NULL
development	NULL
.	NULL

Bur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:3231-3239.	NULL
.	NULL

Micallef	NULL
,	NULL
M.J.	NULL
,	NULL
T.	NULL
Ohtsuki	NULL
,	NULL
K.	NULL
Kohno	NULL
,	NULL
F.	NULL
Tanabe	NULL
,	NULL
S.	NULL
Ushio	NULL
,	NULL
M.	NULL
Namba	NULL
,	NULL
T.	NULL
Tanimoto	NULL
,	NULL
K.	NULL
Torigoe	NULL
,	NULL
M.	NULL
Fujii	NULL
,	NULL
M.	NULL
Ikeda	NULL
,	NULL
S.	NULL
Fukuda	NULL
,	NULL
and	NULL
M.	NULL
Kurimoto	NULL
.	NULL

1996	NULL
.	NULL

Interferon-y-inducing	NULL
factor	NULL
enhances	NULL
T	NULL
helper	NULL
1	NULL
cytokine	NULL
production	NULL
by	NULL
stimulated	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
synergism	NULL
with	NULL
interleukin-12	NULL
for	NULL
interferon-y	NULL
production	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:1647-1651	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Tsutsui	NULL
,	NULL
T.	NULL
Yoshimoto	NULL
,	NULL
O.	NULL
Adachi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Koshimoto	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1998	NULL
.	NULL

Defective	NULL
NK	NULL
cell	NULL
activity	NULL
and	NULL
Th1	NULL
response	NULL
in	NULL
IL-18-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

8:383-390	NULL
Yoshimoto	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Tsutsui	NULL
,	NULL
K.	NULL
Tominaga	NULL
,	NULL
K.	NULL
Hoshino	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
W.E	NULL
.	NULL

Paul	NULL
,	NULL
and	NULL
K.	NULL
Nakanishi	NULL
.	NULL

1999	NULL
.	NULL

IL-18	NULL
,	NULL
although	NULL
antiallergic	NULL
when	NULL
administered	NULL
with	NULL
IL-12	NULL
,	NULL
stimulates	NULL
IL-4	NULL
and	NULL
histamine	NULL
release	NULL
by	NULL
basophils	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sai	NULL
.	NULL

USA	NULL
.	NULL

96:13962-13966	NULL
.	NULL

Yoshimoto	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Mizutani	NULL
,	NULL
H.	NULL
Tsutsui	NULL
,	NULL
N.	NULL
Noben-Trauth	NULL
,	NULL
K.	NULL
Yamanaka	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
S.	NULL
Izumi	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
WE	NULL
.	NULL

Paul	NULL
,	NULL
and	NULL
K.	NULL
Nakanishi	NULL
.	NULL

2000	NULL
.	NULL

IL-18	NULL
induction	NULL
of	NULL
IgE	NULL
:	NULL
dependence	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
IL-4	NULL
and	NULL
STAT6	NULL
.	NULL

Nat	NULL
.	NULL

Immunol	NULL
.	NULL

2:132-137	NULL
.	NULL

Hoshino	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
J.R.	NULL
Ortaldo	NULL
,	NULL
RH	NULL
.	NULL

Wiltrout	NULL
,	NULL
and	NULL
H.A	NULL
.	NULL

Young	NULL
.	NULL

2000	NULL
.	NULL

In	NULL
vivo	NULL
administration	NULL
of	NULL
IL-18	NULL
can	NULL
induce	NULL
IgE	NULL
production	NULL
through	NULL
Th2	NULL
cytokine	NULL
induction	NULL
and	NULL
up-regulation	NULL
of	NULL
CD40	NULL
ligand	NULL
(	NULL
CD154	NULL
)	NULL
expression	NULL
on	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

Bur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:1998-2006	NULL
.	NULL

Hoshino	NULL
,	NULL
T.	NULL
,	NULL
R.H.	NULL
Wiltrout	NULL
,	NULL
and	NULL
H.A	NULL
.	NULL

Young	NULL
.	NULL

1999	NULL
.	NULL

IL-18	NULL
is	NULL
a	NULL
potent	NULL
coinducer	NULL
of	NULL
IL-13	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
new	NULL
potential	NULL
role	NULL
for	NULL
IL-18	NULL
in	NULL
modulating	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:5070-5077	NULL
.	NULL

Torigoe	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Ushio	NULL
,	NULL
T.	NULL
Okura	NULL
,	NULL
S.	NULL
Kobayashi	NULL
,	NULL
M.	NULL
Taniai	NULL
,	NULL
T.	NULL
Kunikata	NULL
,	NULL
T.	NULL
Murakami	NULL
,	NULL
O.	NULL
Sanou	NULL
,	NULL
H.	NULL
Kojima	NULL
,	NULL
M.	NULL
Fujii	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-18	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:25737-25742	NULL
.	NULL

Born	NULL
,	NULL
T.L	NULL
.	NULL

,	NULL
E.	NULL
Thomassen	NULL
,	NULL
T.A	NULL
.	NULL

Bird	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Sims	NULL
.	NULL

1998	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
novel	NULL
receptor	NULL
subunit	NULL
,	NULL
AcPL	NULL
,	NULL
required	NULL
for	NULL
interleukin-18	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:29445-29450	NULL
.	NULL

152	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Parnet	NULL
,	NULL
P.	NULL
,	NULL
K.E	NULL
.	NULL

Garka	NULL
,	NULL
T.P	NULL
.	NULL

Bonnert	NULL
,	NULL
SK	NULL
.	NULL

Dower	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Sims	NULL
.	NULL

1996	NULL
.	NULL

IL-1Rrp	NULL
is	NULL
a	NULL
novel	NULL
receptor-like	NULL
molecular	NULL
similar	NULL
to	NULL
the	NULL
type	NULL
I	NULL
interleukin-1	NULL
receptor	NULL
and	NULL
its	NULL
homologues	NULL
T1/ST2	NULL
and	NULL
IL-1R	NULL
AcP	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:3967-3970	NULL
.	NULL

Thomassen	NULL
,	NULL
E.	NULL
,	NULL
T.A	NULL
.	NULL

Bird	NULL
,	NULL
B.R	NULL
.	NULL

Renshaw	NULL
,	NULL
M.K	NULL
.	NULL

Kennedy	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Sims	NULL
.	NULL

1998	NULL
.	NULL

Binding	NULL
of	NULL
interleukin-18	NULL
to	NULL
the	NULL
interleukin-1	NULL
receptor	NULL
homologous	NULL
receptor	NULL
IL-1Rrp1l	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
signaling	NULL
pathways	NULL
similar	NULL
to	NULL
those	NULL
used	NULL
by	NULL
in-terleukin-1	NULL
.	NULL

J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

18:1077-1088	NULL
.	NULL

O'Neill	NULL
,	NULL
L.A.J	NULL
.	NULL

,	NULL
and	NULL
C.A	NULL
.	NULL

Dinarello	NULL
.	NULL

2000	NULL
.	NULL

The	NULL
interleukin-1	NULL
receptor/toll-like	NULL
receptor	NULL
superfamily	NULL
:	NULL
signal	NULL
transduction	NULL
during	NULL
inflammation	NULL
and	NULL
host	NULL
defense	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

21	NULL
:	NULL
206-209	NULL
.	NULL

Debets	NULL
,	NULL
R.	NULL
,	NULL
J.C.	NULL
Timans	NULL
,	NULL
T.	NULL
Churakowa	NULL
,	NULL
S.	NULL
Zurawski	NULL
,	NULL
R.W	NULL
.	NULL

Malefyt	NULL
,	NULL
K.	NULL
Moore	NULL
,	NULL
J.	NULL
Abrams	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
J.	NULL
Bazan	NULL
,	NULL
and	NULL
R.A.	NULL
Kastelein	NULL
.	NULL

2000	NULL
.	NULL

IL-18	NULL
receptors	NULL
,	NULL
their	NULL
role	NULL
in	NULL
ligand	NULL
binding	NULL
and	NULL
function	NULL
:	NULL
anti-IL-1RAcPL	NULL
antibody	NULL
,	NULL
a	NULL
potent	NULL
antagonist	NULL
of	NULL
IL-18	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:4950-4956	NULL
.	NULL

Hu-Li	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Huang	NULL
,	NULL
J.	NULL
Ryan	NULL
,	NULL
and	NULL
W.E	NULL
.	NULL

Paul	NULL
.	NULL

1997	NULL
.	NULL

In	NULL
differentiated	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
interleukin	NULL
4	NULL
production	NULL
is	NULL
cyto-kine-autonomous	NULL
,	NULL
whereas	NULL
interferon	NULL
y	NULL
production	NULL
is	NULL
cyto-kine-dependent	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sai	NULL
.	NULL

USA	NULL
.	NULL

94:3189-3194	NULL
.	NULL

Xu	NULL
,	NULL
D.	NULL
,	NULL
W.L	NULL
.	NULL

Chan	NULL
,	NULL
B.P	NULL
.	NULL

Leung	NULL
,	NULL
D.	NULL
Hunter	NULL
,	NULL
K.	NULL
Schulz	NULL
,	NULL
R.W	NULL
.	NULL

Carter	NULL
,	NULL
.B	NULL
.	NULL

Mclunes	NULL
,	NULL
J.H	NULL
.	NULL

Robinson	NULL
,	NULL
and	NULL
F.Y	NULL
.	NULL

Liew	NULL
.	NULL

1998	NULL
.	NULL

Selective	NULL
expression	NULL
and	NULL
functions	NULL
of	NULL
interleukin	NULL
18	NULL
receptor	NULL
on	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
type	NULL
1	NULL
but	NULL
not	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:1485-1492	NULL
.	NULL

Yoshimoto	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Takeda	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
K.	NULL
Ohkusu	NULL
,	NULL
S.	NULL
Kashi-wamura	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
and	NULL
K.	NULL
Nakanishi	NULL
.	NULL

1998	NULL
.	NULL

IL-12	NULL
up-regulates	NULL
IL-18	NULL
receptor	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
Th1	NULL
cells	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
:	NULL
synergism	NULL
with	NULL
IL-18	NULL
for	NULL
IFN-y	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3400-3407	NULL
.	NULL

Tomura	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Maruo	NULL
,	NULL
J.	NULL
Mu	NULL
,	NULL
Z.Y	NULL
.	NULL

Zhou	NULL
,	NULL
HJ	NULL
.	NULL

Ahn	NULL
,	NULL
T.	NULL
Hamaoka	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
S.	NULL
Clark	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
and	NULL
H.	NULL
Fujiwara	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
capacities	NULL
of	NULL
CD44	NULL
,	NULL
CD8*	NULL
,	NULL
and	NULL
CD4TCD8~	NULL
T	NULL
cell	NULL
subsets	NULL
to	NULL
express	NULL
IL-18	NULL
receptor	NULL
and	NULL
produce	NULL
IFN-y	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3759-3765	NULL
.	NULL

Chang	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
B.M	NULL
.	NULL

Segal	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
and	NULL
E.M.	NULL
Shevach	NULL
.	NULL

2000	NULL
.	NULL

The	NULL
costimulatory	NULL
effect	NULL
of	NULL
IL-18	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
antigen-specific	NULL
IFN-y	NULL
production	NULL
by	NULL
resting	NULL
T	NULL
cells	NULL
is	NULL
IL-12	NULL
dependent	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
up-regulation	NULL
of	NULL
the	NULL
IL-12	NULL
receptor	NULL
B2	NULL
subunit	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30	NULL
:	NULL
1113-1119	NULL
.	NULL

Kunikata	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Torigoe	NULL
,	NULL
S.	NULL
Ushio	NULL
,	NULL
T.	NULL
Okura	NULL
,	NULL
C.	NULL
Ushio	NULL
,	NULL
H.	NULL
Yamuchi	NULL
,	NULL
M.	NULL
Ikeda	NULL
,	NULL
H.	NULL
Ikegami	NULL
,	NULL
and	NULL
M.	NULL
Kurimoto	NULL
.	NULL

1998	NULL
.	NULL

Constitutive	NULL
and	NULL
induced	NULL
IL-18	NULL
receptor	NULL
expression	NULL
by	NULL
various	NULL
peripheral	NULL
blood	NULL
cell	NULL
subsets	NULL
as	NULL
determined	NULL
by	NULL
anti-hIL-18R	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

189:135-143	NULL
.	NULL

Nakamura	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Otani	NULL
,	NULL
R.	NULL
Okura	NULL
,	NULL
Y.	NULL
Ijiri	NULL
,	NULL
R.	NULL
Motoda	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
and	NULL
K.	NULL
Orita	NULL
.	NULL

2000	NULL
.	NULL

Expression	NULL
and	NULL
responsiveness	NULL
of	NULL
human	NULL
interleukin-18	NULL
receptor	NULL
(	NULL
IL-18R	NULL
)	NULL
on	NULL
hematopoi-etic	NULL
cell	NULL
lines	NULL
.	NULL

Leukemia	NULL
.	NULL

14:1052-1059	NULL
.	NULL

Hoshino	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Tsutsui	NULL
,	NULL
T.	NULL
Kawai	NULL
,	NULL
K.	NULL
Takeda	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
Y.	NULL
Takeda	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1999	NULL
.	NULL

Generation	NULL
of	NULL
IL-18	NULL
receptor-deficient	NULL
mice	NULL
:	NULL
evidence	NULL
for	NULL
IL-1	NULL
receptor-related	NULL
protein	NULL
as	NULL
an	NULL
essential	NULL
IL-18	NULL
binding	NULL
receptor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:5041-5044	NULL
.	NULL

Sareneva	NULL
,	NULL
T.	NULL
,	NULL
I.	NULL
Julkunen	NULL
,	NULL
and	NULL
S.	NULL
Matikainen	NULL
.	NULL

2000	NULL
.	NULL

IFN-and	NULL
IL-12	NULL
induce	NULL
IL-18	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:1933-1938	NULL
.	NULL

Abn	NULL
,	NULL
HJ	NULL
.	NULL

,	NULL
S.	NULL
Maruo	NULL
,	NULL
M.	NULL
Tomura	NULL
,	NULL
J.	NULL
Mu	NULL
,	NULL
T.	NULL
Hanaoka	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
S.	NULL
Clark	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
and	NULL
H.	NULL
Regulation	NULL
of	NULL
IL-18	NULL
Receptor	NULL
Expression	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

Fujiwara	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
mechanism	NULL
underlying	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IFN-y-inducing	NULL
factor	NULL
in	NULL
enhanced	NULL
production	NULL
of	NULL
IFN-y	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:2125-2131	NULL
.	NULL

Heath	NULL
,	NULL
V.L	NULL
.	NULL

,	NULL
E.	NULL
Murphy	NULL
,	NULL
C.	NULL
Crain	NULL
,	NULL
M.	NULL
Tomlinson	NULL
,	NULL
and	NULL
A.	NULL
O'Garra	NULL
.	NULL

2000	NULL
.	NULL

TGF-B1	NULL
down-regulates	NULL
Th2	NULL
development	NULL
and	NULL
results	NULL
in	NULL
decreased	NULL
IL-4-induced	NULL
STAT6	NULL
activation	NULL
and	NULL
GATA-3	NULL
expression	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:2639-2649	NULL
.	NULL

Szabo	NULL
,	NULL
SJ	NULL
.	NULL

,	NULL
A.S.	NULL
Dighe	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-12R	NULL
B2	NULL
subunit	NULL
expression	NULL
in	NULL
developing	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:817-824	NULL
.	NULL

Segal	NULL
,	NULL
B.M	NULL
.	NULL

,	NULL
and	NULL
E.M.	NULL
Shevach	NULL
.	NULL

1996	NULL
.	NULL

IL-12	NULL
unmasks	NULL
latent	NULL
153	NULL
Smeltz	NULL
et	NULL
al	NULL
.	NULL

autoimmune	NULL
disease	NULL
in	NULL
resistant	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:771-	NULL
775	NULL
.	NULL

34	NULL
.	NULL

Xu	NULL
,	NULL
H.	NULL
,	NULL
LV	NULL
.	NULL

Rizzo	NULL
,	NULL
P.B	NULL
.	NULL

Silver	NULL
,	NULL
and	NULL
RR	NULL
.	NULL

Caspi	NULL
.	NULL

1997	NULL
.	NULL

Uveitogenicity	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
-like	NULL
lymphokine	NULL
pro-file	NULL
:	NULL
cytokine-dependent	NULL
modulation	NULL
of	NULL
early	NULL
and	NULL
committed	NULL
effector	NULL
T	NULL
cells	NULL
in	NULL
experimental	NULL
autoimmune	NULL
uveitis	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

178:69-78	NULL
.	NULL

35	NULL
.	NULL

Leite-de-Moraes	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
A.	NULL
Hameg	NULL
,	NULL
M.	NULL
Pacilio	NULL
,	NULL
Y.	NULL
Koezuka	NULL
,	NULL
M.	NULL
Taniguchi	NULL
,	NULL
L.	NULL
Van	NULL
Kaer	NULL
,	NULL
E.	NULL
Schneider	NULL
,	NULL
M.	NULL
Dy	NULL
,	NULL
and	NULL
A.	NULL
Herbelin	NULL
.	NULL

2000	NULL
.	NULL

IL-18	NULL
enhacnes	NULL
IL-4	NULL
production	NULL
by	NULL
ligand-activated	NULL
NK	NULL
T	NULL
lymphocytes	NULL
:	NULL
a	NULL
pro-Th2	NULL
effect	NULL
of	NULL
IL-18	NULL
exerted	NULL
through	NULL
NK	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

166:945-951	NULL
.	NULL

